<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="ppub"/></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS156690</article-id><article-id pub-id-type="doi">10.1101/2022.11.03.515069</article-id><article-id pub-id-type="archive">PPR567136</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title><italic>Shigella</italic> induces epigenetic reprogramming of zebrafish neutrophils</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Gomes</surname><given-names>Margarida C.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib><contrib contrib-type="author"><name><surname>Brokatzky</surname><given-names>Dominik</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Bielecka</surname><given-names>Magdalena K.</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Wardle</surname><given-names>Fiona C.</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Mostowy</surname><given-names>Serge</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="fn" rid="FN1">3</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Infection Biology, London School of Hygiene &amp; Tropical Medicine, London, United Kingdom</aff><aff id="A2"><label>2</label>Randall Centre for Cell and Molecular Biophysics, New Hunt's House, Guy's Campus, King's College London, United Kingdom</aff><author-notes><corresp id="CR1">
<label>*</label>Correspondence: <email>margarida.castro-gomes@lshtm.ac.uk</email> (M.C.G.), <email>serge.mostowy@lshtm.ac.uk</email> (S.M.)</corresp><fn id="FN1"><label>3</label><p id="P1">Lead contact</p></fn></author-notes><pub-date pub-type="nihms-submitted"><day>06</day><month>11</month><year>2022</year></pub-date><pub-date pub-type="preprint"><day>04</day><month>11</month><year>2022</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0 International license</ext-link>.</license-p></license></permissions><abstract><title>Summary</title><p id="P2">Trained immunity is a long-term memory of innate immune cells, generating an improved response upon re-infection. <italic>Shigella</italic> is an important human pathogen and inflammatory paradigm for which there is no effective vaccine. Using zebrafish larvae we demonstrate that after <italic>Shigella</italic> priming neutrophils are more efficient at bacterial clearance. We observe that <italic>Shigella-induced</italic> protection is non-specific and long-lasting, and is unlike training by BCG and β-glucan. Analysis of histone ChIP-seq on primed neutrophils revealed that <italic>Shigella</italic> training deposits the active H3K4me3 mark on promoter regions of 1612 genes, significantly changing the epigenetic landscape of neutrophils towards enhanced microbial recognition and mitochondrial ROS production. Finally, we demonstrate that mitochondrial ROS plays a key role in enhanced antimicrobial activity of trained neutrophils. It is envisioned that signals and mechanisms we discover here can be used in other vertebrates, including humans, to suggest new therapeutic strategies involving neutrophils to control bacterial infection.</p></abstract><kwd-group><kwd>ChIP-seq</kwd><kwd>granulopoiesis</kwd><kwd>H3K4me3</kwd><kwd>neutrophils</kwd><kwd>ROS</kwd><kwd><italic>Shigella</italic></kwd><kwd>trained immunity</kwd><kwd>zebrafish</kwd></kwd-group></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P3">Trained immunity is an immunological memory characterized by remodelling of the epigenetic landscape and metabolism of myeloid cells, conferring enhanced responses upon a new infection challenge <sup><xref ref-type="bibr" rid="R1">1</xref></sup>. The most commonly used training stimuli are <italic>Mycobacterium bovis</italic> Bacille Calmette-Guérin (BCG) and the fungal wall component β-glucan <sup><xref ref-type="bibr" rid="R1">1</xref>–<xref ref-type="bibr" rid="R5">5</xref></sup>, however reports have described a large breadth of triggers that include metabolites, inflammatory cytokines and danger signals <sup><xref ref-type="bibr" rid="R2">2</xref>,<xref ref-type="bibr" rid="R3">3</xref>,<xref ref-type="bibr" rid="R6">6</xref>–<xref ref-type="bibr" rid="R9">9</xref></sup>. Although work <italic>in vitro, ex vivo</italic>, in mice and in humans has mostly been centred around monocytes/macrophages <sup><xref ref-type="bibr" rid="R1">1</xref>,<xref ref-type="bibr" rid="R10">10</xref>,<xref ref-type="bibr" rid="R11">11</xref></sup>, growing evidence shows that mechanisms of trained immunity can be observed in other immune and non-immune cells (such as endothelial and epithelial cells) <sup><xref ref-type="bibr" rid="R12">12</xref>–<xref ref-type="bibr" rid="R16">16</xref></sup>. Recent reports have started to investigate training mechanisms by BCG and β-glucan in neutrophils <sup><xref ref-type="bibr" rid="R17">17</xref>,<xref ref-type="bibr" rid="R18">18</xref></sup>, however the impact of trained neutrophils at a whole animal level is mostly unknown.</p><p id="P4">The zebrafish embryo has been widely used as a model for developmental biology, cell biology and infectious diseases <sup><xref ref-type="bibr" rid="R19">19</xref>–<xref ref-type="bibr" rid="R22">22</xref></sup>. Zebrafish are genetically tractable, share &gt;80% of human genes associated with diseases, and strictly depend upon innate immune responses until 4 weeks post-fertilization when the adaptive immune system starts to develop <sup><xref ref-type="bibr" rid="R23">23</xref>–<xref ref-type="bibr" rid="R25">25</xref></sup>. Seminal studies have used zebrafish as a model to study hematopoietic stem and progenitor cells (HSPCs) development and haematopoiesis <sup><xref ref-type="bibr" rid="R26">26</xref>–<xref ref-type="bibr" rid="R30">30</xref></sup>, and the repertoire of innate immune cells in zebrafish is now well characterized <sup><xref ref-type="bibr" rid="R31">31</xref>,<xref ref-type="bibr" rid="R32">32</xref></sup>. Considering this, the zebrafish model presents itself as an attractive model to study trained immunity. The first evidence that training mechanisms may also be conserved in fish comes from decades of use of β-glucans in aquaculture, where their use improved the resistance of teleost fish to infections <sup><xref ref-type="bibr" rid="R33">33</xref>,<xref ref-type="bibr" rid="R34">34</xref></sup>. Further work with carp macrophages <sup><xref ref-type="bibr" rid="R35">35</xref></sup>, vaccine development <sup><xref ref-type="bibr" rid="R36">36</xref>–<xref ref-type="bibr" rid="R38">38</xref></sup> and pathogenic infections <sup><xref ref-type="bibr" rid="R29">29</xref>,<xref ref-type="bibr" rid="R39">39</xref>,<xref ref-type="bibr" rid="R40">40</xref></sup> support the use of fish as a model to dissect fundamental determinants of trained immunity.</p><p id="P5"><italic>Shigella</italic> is an important human pathogen, among the top 12 priority pathogens requiring urgent action by the World Health Organization <sup><xref ref-type="bibr" rid="R41">41</xref></sup>, and for which there are no effective vaccines <sup><xref ref-type="bibr" rid="R42">42</xref></sup>. <italic>Shigella</italic> infection is well known to induce inflammation, by its lipopolysaccharide (LPS) and type III secretion system (T3SS) <sup><xref ref-type="bibr" rid="R43">43</xref>,<xref ref-type="bibr" rid="R44">44</xref></sup>. We previously demonstrated that hallmarks of <italic>Shigella</italic> infection, including inflammation and macrophage cell death, can be observed using a zebrafish infection model <sup><xref ref-type="bibr" rid="R45">45</xref>–<xref ref-type="bibr" rid="R48">48</xref></sup>. Work has also shown that a non-lethal <italic>Shigella</italic> infection triggers immune responses that lead to emergency granulopoiesis, and protects zebrafish larvae from secondary infection <sup><xref ref-type="bibr" rid="R40">40</xref>,<xref ref-type="bibr" rid="R49">49</xref></sup>.</p><p id="P6">Here we introduce the zebrafish larvae infection model as a powerful system to study innate immune training. We show that <italic>Shigella</italic>-priming of zebrafish larvae generates protective neutrophils, and the training mechanism differs from that of BCG- or β-glucan-priming. Genome-wide sequencing of epigenetic modifications in trimethylation at histone 3 lysine 4 (H3K4me3) in <italic>Shigella</italic>-primed neutrophils and downstream functional characterisation shows that their epigenetic landscape is modified to increase mitochondrial reactive oxygen species (mtROS) production to better fight secondary infectious challenges.</p></sec><sec id="S2" sec-type="results"><title>Results</title><sec id="S3"><title>Zebrafish priming with a non-lethal dose of <italic>Shigella</italic> induces generation of protective neutrophils</title><p id="P7">We previously demonstrated that a non-lethal dose of <italic>Shigella flexneri</italic> injected in the hindbrain ventricle (HBV) of zebrafish larvae at 2 days post-fertilisation (dpf) is rapidly cleared and induces hematopoietic stem and progenitor cell (HSPC) proliferation and differentiation as well as emergency granulopoiesis in the aorta-gonad-mesonephros (AGM) region <sup><xref ref-type="bibr" rid="R40">40</xref></sup>. To better understand the immune responses during a non-lethal <italic>Shigella</italic> infection, we quantified total number of neutrophils and macrophages in larvae injected with ~2x10<sup>3</sup> CFU (<xref ref-type="fig" rid="F1">Fig 1A</xref>). Neutrophil numbers significantly decrease at 24 hours post 1<sup>st</sup> infection (hp1i), and by 48 hp1i the pool of neutrophils is replenished in excess, consistent with observed granulopoiesis in the AGM (<xref ref-type="fig" rid="F1">Fig 1B-C</xref>). Although the macrophage population is also significantly reduced by 24 hp1i, it does not recover by 48 hp1i (<xref ref-type="fig" rid="F1">Fig 1D</xref>), suggesting that macrophage hematopoiesis is impaired to favor granulopoiesis, consistent with previous reports <sup><xref ref-type="bibr" rid="R2">2</xref>,<xref ref-type="bibr" rid="R8">8</xref>,<xref ref-type="bibr" rid="R50">50</xref>,<xref ref-type="bibr" rid="R51">51</xref></sup>.</p><p id="P8">Analysis of cytokine expression showed a significant increase in pro-inflammatory cytokines <italic>cxcl8a, cxcl18b, il1b, il6</italic> and <italic>tnfa</italic> between 6 and 24 hp1i (<xref ref-type="fig" rid="F1">Fig 1E</xref> and <xref ref-type="supplementary-material" rid="SD1">Fig S1A</xref>), which correlates with neutrophil recruitment and bacterial clearance (<xref ref-type="supplementary-material" rid="SD1">Fig S1B</xref>). At 48 hp1i, the pro-inflammatory response induced by <italic>Shigella</italic> priming returns to basal levels, but expression of the anti-inflammatory cytokine <italic>il10</italic> remains elevated. These results are consistent with the requirement of inflammation to induce proliferation of HSPCs <sup><xref ref-type="bibr" rid="R28">28</xref>,<xref ref-type="bibr" rid="R29">29</xref>,<xref ref-type="bibr" rid="R40">40</xref></sup>, and show that primed larvae (<italic>i.e</italic>. those injected with a non-lethal dose of <italic>Shigella</italic>) are at immunological homeostasis prior to reinfection.</p><p id="P9">Upon a 2<sup>nd</sup> lethal <italic>Shigella</italic> challenge (<xref ref-type="fig" rid="F1">Fig 1F</xref>), primed larvae show significantly higher survival rates by 48 hours post 2<sup>nd</sup> infection (hp2i) as compared to naïve larvae (<italic>i.e</italic>. those injected with PBS). Quantification of neutrophil recruitment to the HBV when infected with a lethal dose (&gt;2x10<sup>4</sup> CFU), showed that recruitment in <italic>Shigella</italic>-primed larvae is not significantly different from naïve larvae (<xref ref-type="fig" rid="F1">Fig 1G-H</xref>). At 6 hp2i, bacterial burden in <italic>Shigella</italic>-primed larvae starts to reduce, as compared to naïve larvae (<xref ref-type="fig" rid="F1">Fig 1I</xref>), suggesting that primed neutrophils are better at clearing bacteria. Similarities in neutrophil recruitment in both conditions during infection are consistent with expression of pro-inflammatory cytokines <italic>cxcl8a</italic> and <italic>cxcl18b</italic>, which are expressed to the same extent in naïve and primed larvae at 6 hp2i (<xref ref-type="fig" rid="F1">Fig 1J</xref>). In primed infected larvae, the anti-inflammatory cytokine <italic>il10</italic> expression is significantly different compared to that in naïve larvae (both uninfected and infected), suggesting that primed larvae strongly induce anti-inflammatory responses. At 24 hp2i, all analysed cytokines are less expressed in primed infected larvae compared to naïve infected larvae (<xref ref-type="fig" rid="F1">Fig 1J</xref> and <xref ref-type="supplementary-material" rid="SD1">Fig S1B</xref>). Together, these observations indicate that <italic>Shigella</italic>-primed larvae are protected against a secondary infectious challenge because of tighter control of immune responses and their neutrophils have increased killing capacity, which are important characteristics of innate immune training.</p></sec><sec id="S4"><title><italic>Shigella</italic> innate immune training is non-specific and long lasting</title><p id="P10">Work on trained innate immunity using BCG has demonstrated that induced protection is not specific to <italic>Mycobacterium tuberculosis</italic> (Mtb) and helps in controlling fungal infection by <italic>Candida albicans</italic> <sup><xref ref-type="bibr" rid="R52">52</xref></sup>. In zebrafish, β-glucan and <italic>Salmonella enterica</italic> serovar Typhimurium have been shown to protect against Gram-negative and Gram-positive pathogens <sup><xref ref-type="bibr" rid="R39">39</xref></sup>. Here we tested our <italic>Shigella</italic>-primed larvae against lethal infections of <italic>Pseudomonas aeruginosa</italic> (a Gram-negative pathogen, 2x10<sup>3</sup> CFU), and <italic>Staphylococcus aureus</italic> (a Gram-positive pathogen, 2x10<sup>4</sup> CFU) (<xref ref-type="fig" rid="F2">Fig 2A</xref>). In both cases, the survival of <italic>Shigella</italic>-primed larvae is significantly higher as compared to the survival of naïve larvae (<xref ref-type="fig" rid="F2">Fig 2B-C</xref>), and bacterial burden is controlled from 6 hp2i (<xref ref-type="supplementary-material" rid="SD2">Fig S2A-B</xref>). These results demonstrate that <italic>Shigella</italic>-induced protection of zebrafish is non-specific.</p><p id="P11">To test the longevity of protection induced by <italic>Shigella</italic> priming, we increased the resting interval between priming and reinfection from 2 to 5 days (<xref ref-type="fig" rid="F2">Fig 2D</xref>). At this timepoint (7 dpf), we observed that neutrophil numbers remain higher in primed larvae as compared to naïve larvae (<xref ref-type="fig" rid="F2">Fig 2E-F</xref>), but the differences are smaller than at 4 dpf (<xref ref-type="fig" rid="F1">Fig 1B-C</xref>). Upon reinfection with a lethal dose of <italic>Shigella</italic> (2.5x10<sup>4</sup> CFU), survival of primed larvae is significantly higher compared to naïve larvae (<xref ref-type="fig" rid="F2">Fig 2G</xref>). However, differences in bacterial clearance are less detectable at 24 hp2i between groups (<xref ref-type="supplementary-material" rid="SD2">Fig S2C</xref>).</p></sec><sec id="S5"><title>BCG and β-glucan induce protection in zebrafish larvae</title><p id="P12">BCG and β-glucan have been widely studied as inducers of trained immunity <sup><xref ref-type="bibr" rid="R52">52</xref>,<xref ref-type="bibr" rid="R53">53</xref></sup>. To better understand the mechanisms by which <italic>Shigella</italic> can induce trained immunity, we developed zebrafish reinfection models with BCG and β-glucan for comparison. In the BCG reinfection model (<xref ref-type="fig" rid="F3">Fig 3A</xref>), a low dose of BCG (50 CFU) was injected in 2 dpf larvae that were then incubated at 33 °C for 48 h to stimulate BCG replication <sup><xref ref-type="bibr" rid="R54">54</xref></sup>. Although BCG were not completely cleared from larvae (<xref ref-type="fig" rid="F3">Fig 3C</xref>), reinfection with a lethal dose of <italic>Shigella</italic> was done at 48 hp1i and survival was followed for another 48 h at 28.5 °C. In this case, BCG-primed larvae had significantly greater survival than naïve larvae (<xref ref-type="fig" rid="F3">Fig 3B</xref>), even though they presented a similar burden of <italic>Shigella</italic> at 24 hp2i (<xref ref-type="fig" rid="F3">Fig 3C</xref>). The difference between BCG and <italic>Shigella</italic> training may be associated with pro-inflammatory responses that are induced during priming. Whereas <italic>Shigella</italic> strongly induces pro-inflammatory responses by 6 hp1i (<xref ref-type="fig" rid="F1">Fig 1E</xref>), BCG infection does not (<xref ref-type="fig" rid="F3">Fig 3D</xref>). Surprisingly, the expression of neutrophil chemokines <italic>cxcl8a</italic> and <italic>cxcl18b</italic> were repressed at 6 hp1i, which may explain the lack of neutrophil recruitment to the HBV by 24 hp1i (<xref ref-type="supplementary-material" rid="SD3">Fig S3A</xref>). Macrophages, in contrast, were recruited to the injection site and remained in the HBV until 24 hp1i (<xref ref-type="supplementary-material" rid="SD3">Fig S3B</xref>). Overall, no differences in neutrophil and macrophage numbers were observed during BCG infection (<xref ref-type="fig" rid="F3">Fig 3E-G</xref>).</p><p id="P13">To establish a β-glucan (local) reinfection model (<xref ref-type="fig" rid="F3">Fig 3H</xref>), 20 ng of β-glucan were injected in the HBV of larvae and infection with <italic>Shigella</italic> occurred 48 h after. Larvae primed with β-glucan had increased survival (<xref ref-type="fig" rid="F3">Fig 3I</xref>) and reduced bacterial burden by 24 hp2i (<xref ref-type="fig" rid="F3">Fig 3J</xref>). Analysis of cytokine expression at 6 hp1i demonstrated that <italic>cxcl18b</italic>, <italic>il1b</italic> and <italic>il10</italic> are significantly more expressed in β-glucan primed larvae compared to naïve larvae (<xref ref-type="fig" rid="F3">Fig 3K</xref>), suggesting that β-glucan is recognized by the immune system. Similar to <italic>Shigella</italic> priming, β-glucan induced changes in the neutrophil and macrophage populations. At 24 hp1i the neutrophil numbers were significantly reduced, and by 48 hp1i the population was restored to similar numbers as in naïve larvae (<xref ref-type="fig" rid="F3">Fig 3L-M</xref>). The granulopoiesis observed was associated to expression of <italic>gcsfa</italic> expression at 24 hp1i (<xref ref-type="supplementary-material" rid="SD3">Fig S3F</xref>), but there was no significant increase in the number of neutrophils in the AGM as compared to naïve larvae (<xref ref-type="supplementary-material" rid="SD3">Fig S3G</xref>). Consequently, and similar to <italic>Shigella</italic> priming, macrophage differentiation was blunted by 48 hp1i (<xref ref-type="fig" rid="F3">Fig 3N</xref>).</p><p id="P14">Considering the differences across zebrafish models of trained innate immunity (<xref ref-type="table" rid="T1">Table 1</xref>), we conclude that the priming mechanism induced by <italic>Shigella</italic> is different from that of BCG and β-glucan.</p></sec><sec id="S6"><title>Contribution of host factors, LPS and <italic>Shigella</italic> effectors to training mechanisms</title><p id="P15"><italic>Gcsf</italic> signalling is crucial to induce emergency granulopoiesis in <italic>Shigella</italic>-primed larvae <sup><xref ref-type="bibr" rid="R40">40</xref></sup>, however it is not the only requirement to induce training mechanisms. To better understand triggers for <italic>Shigella</italic>-induced training in zebrafish larvae, we tested different factors important in <italic>Shigella</italic> infection of host cells (<xref ref-type="fig" rid="F3">Fig 3</xref>).</p><p id="P16">As previously described <sup><xref ref-type="bibr" rid="R28">28</xref></sup>, inflammasome activation plays an important role in HSPCs production and <italic>Shigella</italic> has been shown to be a potent activator of inflammasome pathways <sup><xref ref-type="bibr" rid="R43">43</xref>,<xref ref-type="bibr" rid="R44">44</xref></sup>. Therefore, we tested if NLRP3 inflammasome activation by nigericin and glucose in HSPCs is sufficient to induce training. Zebrafish larvae were bathed in either 0.1 μM nigericin or 1% glucose for at least 24 h from 2 dpf, and at 4 dpf larvae were injected with a lethal dose of <italic>Shigella</italic> (<xref ref-type="fig" rid="F4">Fig 4A</xref>). The survival assay showed that independently of exposure time to either nigericin or glucose, no differences in survival (<xref ref-type="fig" rid="F4">Fig 4B-C</xref>) or bacterial burden (<xref ref-type="supplementary-material" rid="SD4">Fig S4A-B</xref>) are observed. These results suggest that inflammasome and caspase-1 activation is not sufficient to induce training.</p><p id="P17">Recently, studies with BCG and <italic>Salmonella</italic> have shown that inactivated or heat-killed bacteria can induce trained immunity mechanisms, however the protection observed upon second challenge is weaker <sup><xref ref-type="bibr" rid="R39">39</xref>,<xref ref-type="bibr" rid="R54">54</xref>,<xref ref-type="bibr" rid="R55">55</xref></sup>. In the case of <italic>Shigella</italic> (<xref ref-type="fig" rid="F4">Fig 4D</xref>), both heat-killed and PFA-killed <italic>Shigella</italic> failed to protect larvae survival upon a secondary lethal dose of <italic>Shigella</italic> (<xref ref-type="fig" rid="F4">Fig 4E</xref> and <xref ref-type="supplementary-material" rid="SD4">Fig S4C</xref>), strongly suggesting that <italic>Shigella</italic> needs to be alive to induce training.</p><p id="P18">To test the role of the lipopolysaccharide (LPS) in training, LPS was used to prime larvae followed by secondary challenge with a lethal dose of <italic>Shigella</italic> (<xref ref-type="fig" rid="F4">Fig 4F</xref> and <xref ref-type="supplementary-material" rid="SD4">Fig S4D-F</xref>). Larvae survival upon a lethal <italic>Shigella</italic> injection was not significantly affected by priming with LPS, highlighting that in our model LPS alone does not induce protection mechanisms. However, complete exposure of lipid A in a <italic>Shigella</italic> Δ<italic>rfaC</italic> mutant (which lacks the O-antigen, outer and inner core of LPS, <sup><xref ref-type="bibr" rid="R56">56</xref></sup>) induced 100% protection upon reinfection with <italic>Shigella</italic> (<xref ref-type="fig" rid="F4">Fig 4G</xref>) and highly efficient bacterial clearance (<xref ref-type="supplementary-material" rid="SD4">Fig S4G</xref>). Virulence assays in zebrafish larvae showed that 1x10<sup>4</sup> CFU of <italic>Shigella rfaC</italic> mutant can cause 100% lethality in 48 hpi, whereas <italic>Shigella</italic> wild-type (WT) only kills 50% of the larvae (<xref ref-type="supplementary-material" rid="SD4">Fig S4H</xref>). The lethality was found to be caused by heighted pro-inflammatory responses, and not due to bacterial burden (<xref ref-type="supplementary-material" rid="SD4">Fig S4I-J</xref>). These results support work showing that stronger pro-inflammatory responses induced during priming can result in better innate immune training <sup><xref ref-type="bibr" rid="R54">54</xref></sup>.</p><p id="P19">Previous work has shown that the T3SS plays a role in training, where a complete and functional T3SS provides more protection than an absent T3SS and its effectors <sup><xref ref-type="bibr" rid="R40">40</xref></sup>. Here we tested the effect of T3SS effectors regulated by the master regulator MxiE <sup><xref ref-type="bibr" rid="R57">57</xref></sup>. Larvae survival upon reinfection showed that <italic>mxiE</italic> regulated effectors do not significantly impact how <italic>Shigella</italic> induces training (<xref ref-type="fig" rid="F4">Fig 4H</xref> and <xref ref-type="supplementary-material" rid="SD4">Fig S4K</xref>). We also tested a <italic>Shigella ospF</italic> mutant, lacking the bacterial immunomodulin OspF <sup><xref ref-type="bibr" rid="R58">58</xref>–<xref ref-type="bibr" rid="R60">60</xref></sup>, where similar results to <italic>mxiE</italic> mutant were obtained (<xref ref-type="supplementary-material" rid="SD4">Fig S4L-M</xref>). These results are consistent with similar levels of virulence observed during infection of zebrafish larvae with <italic>Shigella</italic> Δ<italic>mxiE</italic> and Δ<italic>ospF</italic> mutants and <italic>Shigella</italic> WT (<xref ref-type="supplementary-material" rid="SD4">Fig S4N-Q</xref>).</p><p id="P20">Together these data suggest that live <italic>Shigella</italic>, with a functional T3SS, is required to induce inflammatory responses that trigger training mechanisms.</p></sec><sec id="S7"><title>Exposure to <italic>Shigella</italic> induces epigenetic reprogramming of neutrophils</title><p id="P21">Epigenetic reprogramming is a defining characteristic underlying the innate immune training of myeloid cells and the enrichment of trimethylation of lysine 4 at histone 3 (H3K4me3) on gene promoter regions is typically associated to active/poised gene transcription <sup><xref ref-type="bibr" rid="R1">1</xref></sup>. Considering this, we investigated if <italic>Shigella</italic>-primed neutrophils exhibit different H3K4me3 patterns that could explain their ability to better respond to reinfection. To test this, neutrophils were FACS sorted from naïve and primed (<italic>Shigella</italic> WT and <italic>Shigella</italic> ΔT3SS (i.e. <italic>mxiD</italic> mutant)) larvae at 48 hp1i (<xref ref-type="supplementary-material" rid="SD5">Fig S5A</xref>) and chromatin immunoprecipitation sequencing (ChIP-seq) was performed on the H3K4me3 mark (<xref ref-type="fig" rid="F5">Fig 5A</xref>). Genes were then annotated if they had a H3K4me3 mark in their promoter region (defined as ±3kb from the transcription start site; <xref ref-type="supplementary-material" rid="SD7">Tables S1-S3</xref>). Naïve neutrophils displayed H3K4me3 peaks at the promoter region of 1049 genes, which are associated with normal cell functioning (<xref ref-type="supplementary-material" rid="SD5">Fig S5B-C</xref>), including surveying the quality of mRNA to increase the fidelity of RNA processing. Strikingly, neutrophil samples primed with <italic>Shigella</italic> WT or ΔT3SS showed an increase in the number of genes marked by H3K4me3 (2242 and 2707 respectively) as compared to naïve neutrophils, suggesting epigenetic remodelling of primed neutrophils (<xref ref-type="fig" rid="F5">Fig 5B and C</xref>, <xref ref-type="supplementary-material" rid="SD5">Fig S5D-E</xref>).</p><p id="P22">Upon <italic>Shigella</italic> ΔT3SS priming, pathway analysis of marked gene promoter regions indicates that some modulated responses are common to <italic>Shigella</italic> WT-priming, however many other different signalling pathways are affected (<xref ref-type="fig" rid="F5">Fig 5C</xref> and <xref ref-type="supplementary-material" rid="SD7">Table S2</xref>), highlighting that priming with <italic>Shigella</italic> WT leads to a more precise and efficient immune response. <italic>Shigella</italic> WT induced H3K4me3 deposition at promoter regions was observed for genes involved in cellular senescence and in infection signalling pathways, specifically associated to infections by Gram-negative pathogens (<xref ref-type="fig" rid="F5">Fig 5E</xref>). The analysis suggests that primed neutrophils have metabolic and gene expression alterations linked to senescence, and also activation of innate immune signalling via MAPK signalling pathway to express pro-inflammatory cytokines, chemokines, and antimicrobial peptides. In addition, although most promoter regions of pro-inflammatory cytokines are not marked by H3K4me3, deposition of this mark was found in promoter regions of cytokine receptors <italic>il10rb</italic>, <italic>tgfbr1b</italic>, <italic>ifngr1l</italic>, <italic>cxcr3.2</italic> and <italic>cxcr3.3</italic> (<xref ref-type="supplementary-material" rid="SD7">Table S3</xref>). These results highlight the signalling pathways that may be activated and their importance for cell survival and immunomodulation.</p></sec><sec id="S8"><title>Reprogramed neutrophils produce more mitochondrial ROS for enhanced antimicrobial function</title><p id="P23">The ChIP-seq dataset strongly suggested increased mitochondrial ROS (mtROS) production upon <italic>Shigella</italic> WT priming (<xref ref-type="fig" rid="F5">Fig 5E</xref>). In agreement, we found the promoter regions of the genes encoding MCU and VDAC transporters (mitochondrial permeability transition pore (mPTP)), as well as several genes involved in the tricarboxylic acid cycle and oxidative phosphorylation (<xref ref-type="fig" rid="F6">Fig 6A</xref> and <xref ref-type="supplementary-material" rid="SD7">Table S3</xref>) are marked by H3K4me3 in <italic>Shigella</italic> WT-primed but not in naïve larvae. To test if mtROS production was increased in primed neutrophils, we used flow cytometry to quantify MitoTracker CM-H<sub>2</sub>XRos dye in naïve and <italic>Shigella</italic>-primed neutrophils in resting and re-stimulated state at 6 hp2i. Quantifications show that naïve neutrophils when infected with <italic>Shigella</italic> have reduced mtROS, compared to unstimulated neutrophils (<xref ref-type="fig" rid="F6">Fig 6B</xref>). Primed neutrophils also present lower levels of mtROS when unstimulated, however after 6 hp2i mtROS levels are significantly increased as compared to unstimulated naïve and primed neutrophils.</p><p id="P24">Given the redox crosstalk between mitochondria and NADPH oxidases <sup><xref ref-type="bibr" rid="R61">61</xref></sup>, we investigated total ROS production in neutrophils using CellROX dye. Quantifications showed that naïve neutrophils when infected (6 hp2i) have significantly lower total ROS levels as compared to unstimulated state (<xref ref-type="fig" rid="F6">Fig 6C</xref>). <italic>Shigella</italic>-primed neutrophils in resting phase showed higher levels of ROS, compared to naïve unstimulated neutrophils. However, when primed neutrophils became stimulated, total ROS levels decreased, but not to the same extent as in naïve infected neutrophils. The effect of both mtROS and ROS on bacterial killing was tested by adding specific inhibitors of mPTP (cyclosporin A (CsA)) and NADPH oxidase (diphenyleneiodonium chloride (DPI)) to naïve and <italic>Shigella</italic>-primed larvae bath during the 6 hp2i. Recovered CFU showed that inhibitors had more impact in bacterial burden control in <italic>Shigella</italic>-primed larvae than in naïve larvae (<xref ref-type="supplementary-material" rid="SD6">Fig S6B-C and S6E-F</xref>), suggesting that both mtROS and ROS are responsible for improved bacterial clearance in primed larvae.</p><p id="P25">To test if trained immunity can impact other aspects of host defence, we investigated the levels of myeloperoxidase (MPO) in trained neutrophils. Using the transgenic zebrafish line Tg(<italic>mpx</italic>::GFP) in which GFP expression is driven by the myeloperoxidase promoter, we quantified MPO production using FACS. In agreement with its absence from ChIP-seq analysis, we did not observe significant differences in MPO production between naïve and primed neutrophils when reinfected (<xref ref-type="supplementary-material" rid="SD6">Fig S6G</xref>), highlighting the specificity of the <italic>Shigella</italic> training towards mitochondrial ROS production.</p><p id="P26">Together these findings suggest that <italic>Shigella</italic>-trained neutrophils sustain H3K4me3 modifications that result in enhanced antimicrobial function via mtROS in preparation for a second challenge.</p></sec></sec><sec id="S9" sec-type="discussion"><title>Discussion</title><p id="P27">Here we introduce the use of zebrafish larvae to study innate immune training, demonstrating that local infection by <italic>Shigella</italic>, BCG and β-glucan induce non-specific protective effects. The zebrafish larval model is a highly attractive training model – as compared to <italic>in vitro</italic> (single cell type system) and mouse models – as it is a vertebrate model with only innate immune responses during its first ~4 weeks of development.</p><p id="P28">Most work on trained immunity has been largely focused on monocytes and macrophages. However, there is growing evidence that neutrophils also play important roles upon training <sup><xref ref-type="bibr" rid="R17">17</xref>,<xref ref-type="bibr" rid="R18">18</xref></sup>. In the case of <italic>Shigella</italic> infection, macrophages are unable to control infection as bacteria induce cell death programmes <sup><xref ref-type="bibr" rid="R43">43</xref>,<xref ref-type="bibr" rid="R45">45</xref>,<xref ref-type="bibr" rid="R62">62</xref></sup>. Although neutrophils can also be killed by <italic>Shigella</italic>, they resist for longer than macrophages and can rapidly eliminate bacteria <sup><xref ref-type="bibr" rid="R43">43</xref>,<xref ref-type="bibr" rid="R45">45</xref></sup>. Here we show that <italic>Shigella</italic> infection induces production of new neutrophils that are more protective and have better killing capacity than naïve neutrophils. We show that this enhanced infection control is linked to host control of its inflammatory state, which also contributes to increased survival upon a secondary infectious challenge. <italic>Shigella</italic>-priming protects against Gram-negative bacteria (as <italic>Shigella</italic> and <italic>P. aeruginosa</italic>) and also Gram-positive bacteria (as <italic>S. aureus</italic>), suggesting that it induces heterologous immunological memory.</p><p id="P29">To test the hypothesis that <italic>Shigella</italic> induces long-lasting training mechanisms in zebrafish larvae, we extended the interval between infections to 5 days and observed protection against <italic>Shigella</italic> in those larvae. Although protection levels might wane, this is in agreement with the decline of BCG-induced protection after vaccination <sup><xref ref-type="bibr" rid="R63">63</xref>,<xref ref-type="bibr" rid="R64">64</xref></sup>. In the future it will be of great interest to test adult zebrafish (&gt; 3 months) as well as investigate if <italic>Shigella</italic>-training mechanisms can be transmitted trans-generationally in zebrafish as shown using mice <sup><xref ref-type="bibr" rid="R65">65</xref>–<xref ref-type="bibr" rid="R67">67</xref></sup>. We envision that with the practices of zebrafish laboratories to maintain adequate levels of heterozygosity <sup><xref ref-type="bibr" rid="R68">68</xref></sup>, by consistently outbreeding their stocks (unlike mouse lines) the zebrafish model can be used to complement the mouse model aiming to elucidate transmission of trained immunity in humans.</p><p id="P30">Work in zebrafish has shown that BCG vaccination protects against <italic>Mycobacterium marinum</italic> and that β-glucan (systemic) protects against <italic>Salmonella</italic> Typhimurium <sup><xref ref-type="bibr" rid="R36">36</xref>,<xref ref-type="bibr" rid="R39">39</xref></sup>. Both BCG and β-glucan induced protection against <italic>Shigella</italic> infection, and yet had important differences that highlight distinct pathways that each stimuli uses to induce training (<xref ref-type="table" rid="T1">Table 1</xref>). Consistent with this, work using mice has shown that BCG induces training via NOD2 receptor and β-glucan via dectin-1 receptor <sup><xref ref-type="bibr" rid="R52">52</xref>,<xref ref-type="bibr" rid="R53">53</xref>,<xref ref-type="bibr" rid="R69">69</xref></sup>. Although <italic>Shigella</italic>-priming phenotypes in zebrafish share similarities with those from BCG- and β-glucan-priming (such as non-specific protection and enhanced survival upon new infection), the H3K4me3 enriched pathways following <italic>Shigella</italic> training differ from those found in BCG-trained human neutrophils <sup><xref ref-type="bibr" rid="R17">17</xref></sup>, which supports our conclusion that both stimuli induce different training mechanisms in neutrophils. Our findings suggest that <italic>Shigella</italic>-priming is multifactorial, depending on <italic>Shigella</italic> recognition by innate immune receptors, strong cytokine production, and an active T3SS.</p><p id="P31">Enriched pathways from our ChIP-seq datasets indicate that mtROS is playing an important role in enhancing antimicrobial activity of <italic>Shigella</italic>-primed neutrophils. Historically, ROS production in neutrophils has been associated with NADPH oxidase, and therefore the bactericidal role of mtROS in neutrophils has remained mostly elusive. However, recent work in human neutrophils suggested that mitochondria generated ROS enhanced bactericidal activity <sup><xref ref-type="bibr" rid="R70">70</xref></sup>. In agreement, our work highlights that mtROS in neutrophils plays a key role in bacterial killing, and we envision that future therapeutic strategies could manipulate mtROS by using pro-oxidants (such as SkQN <sup><xref ref-type="bibr" rid="R71">71</xref></sup> or MitoK3 <sup><xref ref-type="bibr" rid="R72">72</xref></sup>) specifically targeted to mitochondria in neutrophils.</p><p id="P32">Decades of research have tried to generate a vaccine with sufficient efficacy that could be used against different <italic>Shigella</italic> serotypes in humans <sup><xref ref-type="bibr" rid="R73">73</xref>–<xref ref-type="bibr" rid="R75">75</xref></sup>. Our long-term goal is to guide vaccine studies in humans, exploiting innate immune memory to combat <italic>Shigella</italic> infections. A variety of animal models have significantly contributed to understanding shigellosis and feasibility of vaccines to combat it. We highlight zebrafish as an important animal model to investigate how innate immune training can be manipulated to control <italic>Shigella</italic> infection. It is next of great interest to train neutrophils using live <italic>Shigella</italic> in humans. In this way, we can discover fundamental components of immunity shared between zebrafish and humans that can be trained to promote a better immune response and combat <italic>Shigella</italic> infection.</p></sec><sec id="S10" sec-type="materials | methods"><title>Materials And Methods</title><sec id="S11"><title>Ethics statements</title><p id="P33">Animal experiments were performed according to the Animals (Scientific Procedures) Act 1986 and approved by the Home Office (Project licenses: PPL P84A89400 and P4E664E3C).</p></sec><sec id="S12"><title>Zebrafish husbandry</title><p id="P34">Embryos were obtained from naturally spawning zebrafish and larvae were maintained at 28.5°C in embryo medium (0.5X E2 medium), unless specified otherwise. Transgenic zebrafish lines used here were Tg(<italic>lyz::</italic>dsRed)<sup>nz50 <xref ref-type="bibr" rid="R76">76</xref></sup>, Tg(<italic>mpx::</italic>GFP)<sup>i114 <xref ref-type="bibr" rid="R77">77</xref></sup>, Tg(<italic>mpeg1</italic>::Gal4-FF)<sup>gl25</sup>/Tg(UAS-E1b::<italic>nfsB</italic>.mCherry)<sup>c264 <xref ref-type="bibr" rid="R78">78</xref></sup>. For injections and live microscopy, larvae were anaesthetized with 200 μg/ml tricaine (Sigma-Aldrich) in embryo medium. For injections in larvae &gt; 5 dpf, lidocaine (2 μg/L) was used as an analgesic and added to the embryo medium (together with 200 μg/ml tricaine (Sigma-Aldrich)) prior to injection. After checking for full recovery from the anaesthetic, larvae were kept in E2 medium with lidocaine (2 μg/L) for 18-24 h at 28.5°C. Larvae were monitored for appearance, righting reflex, reactive reflex and opercular movement from day 5 dpf for 2-3 times a day. Larvae were not fed during the course of the experiment <sup><xref ref-type="bibr" rid="R79">79</xref></sup>.</p></sec><sec id="S13"><title>Zebrafish injections</title><p id="P35">Bacterial strains used in this study can be found in <xref ref-type="supplementary-material" rid="SD7">Table S4</xref>. <italic>Shigella, Pseudomonas</italic> and <italic>Staphylococcus</italic> strains were grown on trypticase soy agar (TSA, Sigma-Aldrich) plates with the appropriate antibiotics – for <italic>Shigella</italic> growth, plates were supplemented with 0.01% Congo red (Sigma-Aldrich). Overnight cultures were grown from individual colonies at 37°C and 200 rpm, in 5 ml trypticase soy broth (TSB, Sigma-Aldrich and Oxoid for <italic>Staphylococcus</italic>) supplemented with the appropriate antibiotics as above. For injections, bacteria were grown until an optical density (OD) of 0.55–0.65 at 600 nm (log phase) by diluting the overnight culture 50X in fresh TSB supplemented with the appropriate antibiotics. When in log phase, bacteria were spun down and washed in phosphate buffer saline (PBS, Sigma-Aldrich). The desired concentration was achieved by resuspension of bacteria in injection buffer (2% polyvinyl-pyrrolidone (PVP, Sigma-Aldrich) in PBS and 0.5% phenol red (Sigma-Aldrich)). Control groups were injected with injection buffer (referred as PBS/naïve group).</p><p id="P36">For inactivated bacteria injections suspensions were prepared as described above and, prior to injection, were incubated for 30 min at 60˚C for heat-killing or incubated in 4% paraformaldehyde (PFA, Sigma-Aldrich) for 30 min at RT for PFA-killing.</p><p id="P37">BCG was grown in 7H9 broth (supplemented with 10 % ADC enrichment medium, 0.2 % glycerol and 0.02 % Tween-80) until OD 0.5-0.6. The culture was then spun down and washed with PBS. The suspension was then centrifuged and resuspended in PVP to prevent large clumps. Single cell suspensions were obtained by passing the bacteria through different gauge syringes (25G, 27G and 29G) 10 times each. After achieving the desired concentration, bacteria were resuspended in injection buffer with higher concentration of PVP (4%).</p><p id="P38">A stock solution of β-glucan (Invivo Biosystems cat no. tlrl-bgp) was prepared at 20mg/mL in PBS and stored at 4 °C for a maximum of a month. For injections, indicated dilutions were prepared in injection buffer. Different amounts of β-glucan were first injected in the HBV of larvae to test for dose dependent protection (<xref ref-type="supplementary-material" rid="SD3">Fig S3C-E</xref>). The highest amount tested (20 μg/μL) was chosen as it suggested stronger protection responses.</p><p id="P39">Lipopolysaccharide (LPS, Sigma-Aldrich cat no. L6143) was prepared to mimic the amount of bacteria injected in a non-lethal dose (2500 CFU). According to <sup><xref ref-type="bibr" rid="R80">80</xref></sup>, 2500 bacterial cells in exponential phase would correspond to 0.125 ng of LPS. Therefore, a stock solution of 0.25 mg/mL LPS in PBS was prepared, and prior before injection was mixed 1:1 with 0.5% phenol red.</p><p id="P40">For injection, 1–2 nl of bacterial / β-glucan / LPS suspension or control solution were microinjected in the hindbrain ventricle (HBV) of zebrafish larvae.</p><p id="P41">For bacterial enumeration, larvae tissues were disrupted in 0.4% Triton X-100 (Sigma-Aldrich) with the aid of mechanical pestles, and serial dilutions were plated in the appropriate medium at the indicated timepoints. Plates were incubated at 37°C and colony forming units (CFU) were enumerated when colonies were visible.</p></sec><sec id="S14"><title>Design of <italic>S. flexneri</italic> Δ<italic>ospF</italic> mutant</title><p id="P42"><italic>S. flexneri</italic> Δ<italic>ospF</italic> mutant was created using a λ-Red-mediated recombination <sup><xref ref-type="bibr" rid="R81">81</xref></sup>. In brief, pKD4 plasmid was used as template to amplify a kanamycin resistance-encoding DNA cassette using primers containing 50□bp nucleotides homologous to the site of insertion (<xref ref-type="supplementary-material" rid="SD7">Table S4</xref>). <italic>S. flexneri</italic> electrocompetent cells producing λ-Red recombinase were electroporated with resulting PCR fragments. Electroporated cells were then plated in TSA plates supplemented with 0.01% of Congo red and 50□μg/ml of kanamycin. To remove the kanamycin resistance-encoding DNA cassette, bacteria were transformed with pCP20 plasmid (that encodes the yeast <italic>flp</italic> recombinase, <sup><xref ref-type="bibr" rid="R82">82</xref></sup>). Deletions were verified by PCR using confirmation primers in <xref ref-type="supplementary-material" rid="SD7">Table S4</xref>.</p></sec><sec id="S15"><title>Microscopy and image analysis</title><p id="P43">Whole larvae and HBV images were acquired using stereo fluorescent microscope Leica M205FA (Leica, Germany), and by placing anaesthetised larvae on 1% agarose-E2 plates. Image files were processed using ImageJ/FIJI software. Whole larvae leukocyte quantification was performed according to <sup><xref ref-type="bibr" rid="R83">83</xref></sup> with modifications. In brief, fluorescent images were converted to binary in ImageJ/FIJI, resulting in images in which fluorescence was converted into black pixels onto a white background. For each image, pixels of 5 individual cells were quantified. Total pixel count of each larvae was divided by the average of 5 individual leukocytes to determine total number of cells. Leukocyte quantification in the HBV was determined manually in the region highlighted in <xref ref-type="fig" rid="F1">Fig 1G</xref>.</p></sec><sec id="S16"><title>Zebrafish chemical treatments</title><p id="P44">For inflammasome stimulation, larvae were kept at 28.5°C in E2 medium with 0.1 μM Nigericin (Sigma-Aldrich cat no. 481990-5MG) or 1 % D-glucose (Sigma-Aldrich cat no. G8270-100G) <sup><xref ref-type="bibr" rid="R28">28</xref></sup> for 24, 48 or 96 h from 2 dpf. For NAPDH ROS and mitochondrial ROS inhibition after the 2<sup>nd</sup> infection, larvae were kept at 28.5°C in E2 medium with 100 μM diphenyleneiodonium chloride (DPI, Sigma-Aldrich cat no. D2926) <sup><xref ref-type="bibr" rid="R84">84</xref></sup> and 10 μM cyclosporin A (CsA, Enzo Life Sciences cat no. BML-A195-0100) <sup><xref ref-type="bibr" rid="R85">85</xref></sup>, both in DMSO, for 6 h until larvae were dissociated for flow cytometry. Control larvae were kept in E2 with 1% DMSO.</p></sec><sec id="S17"><title>RNA extraction, cDNA synthesis and qRT-PCR</title><p id="P45">RNA was extracted from 5-10 snap-frozen larvae with the RNeasy Mini kit (Qiagen cat no. 74104) and reverse-transcribed using QuantiTect Reverse Transcription kit (Qiagen cat no 205311) according to manufacturer’s instructions. Quantitative PCR (qPCR) was performed using 7500 Fast Real-Time PCR System machine and 7500 Fast Real-Time PCR software v2.3 (Applied Biosystems, Foster City, California) and SYBR green master mix (Applied Biosystems cat no. 10187094). Template cDNA was subjected to PCR using primers described in <xref ref-type="supplementary-material" rid="SD7">Table S4</xref> and samples were run in technical duplicates. The comparative Ct method was used for gene expression quantification, and <italic>ef1a1l1</italic> was used as the housekeeping gene.</p></sec><sec id="S18"><title>Flow cytometry</title><p id="P46">Tg(<italic>lyz::</italic>dsRed)<sup>nz50</sup> and Tg(<italic>mpx::</italic>GFP)<sup>i114</sup> transgenic larvae were dissociated for flow cytometry following the protocol from <sup><xref ref-type="bibr" rid="R86">86</xref></sup>, with some modifications. In brief, 20 to 100 larvae were washed twice in calcium-free Ringer’s solution for 10 min with slow shaking at RT. After removal of Ringer’s solution, 2 mL of dissociation solution (0.5% Trypsin EDTA 10x no phenol (Fisher cat no.15400054)) was added. Larvae were incubated twice for 10 min at 28.5°C, with gentle pipetting in between incubations to help tissue digestion. The reaction was stopped by adding 10% foetal calf serum (Fisher cat no. 11550356). The suspensions were sieved using 70 μm Nylon cell strainers (Merck CLS431751-50EA) or cell strainer snap caps from test tubes (Corning 352235) and then gently centrifuged for 3 min at 800g. Cells were then washed with 1mL PBS with 10 mM HEPES and 1 mM EDTA. For live/dead staining, cells were incubated with either LIVE/DEAD™ fixable near IR dead cell stain (1:2000, Thermofisher cat no. L34994) or LIVE/DEAD™ fixable violet dead cell stain (1:2000, Thermofisher cat no. L34964) dyes for 30 min at 4°C. Cells were fixed with 4% PFA for 10 min at RT for flow cytometry. For ROS staining, 5μM CellROX™ Deep Red (Thermofisher cat no. C10422) was added to the E2 medium for 30 min prior to larvae dissociation and the larvae were kept in the dark at 28.5°C. Single cells were measured on a LSRII (BD Biosciences). For mitochondrial ROS staining, 300 nM MitoTracker™ Red CM-H<sub>2</sub>XRos (Thermofisher cat no. M7513) was added to the dissociated cells for 30 min at 28.5°C. Single cells were measured on a FACSAria III cell sorter (BD Biosciences). Data was analysed with FlowJo software v10.7.1. To prepare samples for ChIP-seq, cells were fixed with 1% formaldehyde for 8 min at RT with occasional mixing. To stop the reaction 100 μL of glycine 1.25 M were added and the samples were incubated for 5 min at RT. After centrifuging at 600g for 10 min at 4°C, cells were washed with ice cold PBS containing protease inhibitor cocktail (Sigma-Aldrich cat no. 5892970001) and centrifuged again. Cells were then resuspended in PBS with 10mM HEPES and 1 mM EDTA. FACS sorting was done on a FACSAria III cell sorter (BD Biosciences). Data was analysed with BD FACSDiva software. Gating strategies can be found in <xref ref-type="supplementary-material" rid="SD5">Fig S5A</xref> for neutrophil sorting, in <xref ref-type="supplementary-material" rid="SD6">Fig S6A</xref> for mitochondrial ROS measurement and <xref ref-type="supplementary-material" rid="SD6">Fig S6D</xref> for CellROX measurement.</p></sec><sec id="S19"><title>ChIP-seq and analysis</title><p id="P47">For ChIP experiments, a minimum of 20 000 sorted Tg(<italic><underline>lyz</underline></italic>:dsRed) neutrophils were collected per sample (PBS, <italic>Shigella, Shigella</italic> ΔT3SS) and per replicate (each biological replicate corresponds to two experiments). Cells were kept at -80oC until sequencing. ChIP-seq was conducted by Diagenode ChIP-seq/ChIP-qPCR Profiling service (Diagenode cat no. G02010000). Chromatin was prepared for ChIPseq using the True MicroChIP Kit (Diagenode cat no. C01010130) and was sheared using Bioruptor® Pico sonication device (Diagenode cat no. B01060001) combined with the Bioruptor® Water cooler for 5 cycles using a 30” [ON] 30’’ [OFF] settings. Optimization of shearing conditions was done on chromatin corresponding to 10 000 cells. Immunoprecipitation was done on chromatin corresponding to the remaining 10 000 cells using antibodies against H3K4me3 (Diagenode, cat no. C15410003) – 10% of the chromatin was used for input. Libraries were prepared using IP-Star® Compact Automated System (Diagenode cat no. B03000002) from input and ChIP’d DNA using MicroPlex Library Preparation Kit v2 (12 indices) (Diagenode cat no. C05010013). Libraries were pooled and sequenced with Illumina Novaseq 6000, running NovaSeq Control Software 1.6.0, with paired-end reads of 50bp length. Quality control of sequencing reads was performed using FastQC <sup><xref ref-type="bibr" rid="R87">87</xref></sup>.</p><p id="P48">ChIP-sequencing reads were analysed using the Galaxy platform (usegalaxy.eu). Reads were aligned to the reference genome GRCz10 using the Bowtie2 software <sup><xref ref-type="bibr" rid="R88">88</xref></sup> and PCR duplicates were removed with MarkDuplicates <sup><xref ref-type="bibr" rid="R89">89</xref></sup>. Peak calling was performed using MACS2 callpeak <sup><xref ref-type="bibr" rid="R90">90</xref></sup> and the narrow peaks lists were used in IDR <sup><xref ref-type="bibr" rid="R91">91</xref></sup> to identify reproducible peaks between replicates. Finally, ChIPseeker <sup><xref ref-type="bibr" rid="R92">92</xref></sup> was used for peak annotation with a promoter defined as ±3kb around the transcription start site. IGV v2.9.4 <sup><xref ref-type="bibr" rid="R93">93</xref></sup> was used for peak visualisation.</p><p id="P49">For pathway annotation, the lists of genes associated with promoter regions highlighted in bold in <xref ref-type="fig" rid="F5">Fig 5B and 5D</xref>, <xref ref-type="supplementary-material" rid="SD5">Fig S5B and S5D</xref> (PBS, <italic>Shigella</italic> WT, <italic>Shigella</italic> ΔT3SS) were analysed against KEGG pathways in Cytoscape v3.9.1 <sup><xref ref-type="bibr" rid="R94">94</xref></sup> using the plug-in ClueGO v2.5.9 <sup><xref ref-type="bibr" rid="R95">95</xref></sup>.</p></sec><sec id="S20"><title>Resource availability</title><sec id="S21"><title>Lead Contact</title><p id="P50">Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Serge Mostowy at London School of Hygiene &amp; Tropical Medicine, United Kingdom (<email>serge.mostowy@lshtm.ac.uk</email>).</p></sec><sec id="S22"><title>Materials Availability</title><p id="P51">All unique/stable reagents generated in this study are available from the Lead Contact without restriction.</p></sec></sec><sec id="S23"><title>Statistical analysis</title><p id="P52">Statistical significance was determined using GraphPad Prism v9. For differences in survival curves, the Log-rank (Mantel-Cox) test was used. Data from bacterial burden and gene expression levels were Log10- or Log2-transformed, respectively. Pairwise comparisons were determined using a Student’s unpaired <italic>t</italic>-test. For multiple comparisons, one-way or two-way ANOVA tests with Sidak’s correction were used, as indicated in the figure legend.</p></sec></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplemental Figure 1</label><media xlink:href="EMS156690-supplement-Supplemental_Figure_1.pdf" mimetype="application" mime-subtype="pdf" id="d78aAdEbB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD2"><label>Supplemental Figure 2</label><media xlink:href="EMS156690-supplement-Supplemental_Figure_2.pdf" mimetype="application" mime-subtype="pdf" id="d78aAdEcB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD3"><label>Supplemental Figure 3</label><media xlink:href="EMS156690-supplement-Supplemental_Figure_3.pdf" mimetype="application" mime-subtype="pdf" id="d78aAdEdB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD4"><label>Supplemental Figure 4</label><media xlink:href="EMS156690-supplement-Supplemental_Figure_4.pdf" mimetype="application" mime-subtype="pdf" id="d78aAdEeB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD5"><label>Supplemental Figure 5</label><media xlink:href="EMS156690-supplement-Supplemental_Figure_5.pdf" mimetype="application" mime-subtype="pdf" id="d78aAdEfB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD6"><label>Supplemental Figure 6</label><media xlink:href="EMS156690-supplement-Supplemental_Figure_6.pdf" mimetype="application" mime-subtype="pdf" id="d78aAdEgB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD7"><label>Supplementary Materials</label><media xlink:href="EMS156690-supplement-Supplementary_Materials.pdf" mimetype="application" mime-subtype="pdf" id="d78aAdEhB" position="anchor"/></supplementary-material></sec></body><back><ack id="S24"><title>Acknowledgements</title><p>We thank Mostowy lab members, in particular Vincenzo Torraca, Damián Lobato-Márquez and Ana Teresa López-Jiménez, for helpful discussions. We thank Alain Filloux for providing <italic>P. aeruginosa</italic>. We thank Tracy Palmer for providing <italic>S. aureus</italic>. We thank Marcel Behr for providing BCG. We thank Felix Randow for providing <italic>S. flexneri</italic> Ruby strains. We thank the LSHTM Biological Services Facility for the work and care of our fish stocks. We thank Tomek Prasjnar for troubleshooting embryo dissociation protocols. We thank Imperial College London Flow Cytometry Facility South Kensington, in particular Larissa Zarate-Garcia and Jane Srivastava, for their help with neutrophil sorting. We thank Diagenode for the work and helpful discussions on ChIPseq. Research in the F.C.W. laboratory is supported by the BBSRC (BB/R016283/). Research in S.M. laboratory is supported by a European Research Council Consolidator Grant (772853 - ENTRAPMENT), Wellcome Trust Senior Research Fellowship (206444/Z/17/Z) and the Lister Institute of Preventive Medicine.</p></ack><sec id="S25" sec-type="data-availability"><title>Data and Code Availability</title><p id="P53">The ChIP sequencing data of neutrophils 48 h post <italic>Shigella</italic> priming as reported in this paper can been found in the NCBI Gene Expression Omnibus under accession number GEO: GSE217063.</p></sec><fn-group><fn id="FN2" fn-type="con"><p id="P54"><bold>Author Contributions</bold></p><p id="P55">Conceptualization M.C.G., S.M.</p><p id="P56">Methodology M.C.G., D.B., M.K.B.</p><p id="P57">Software M.C.G., D.B., M.K.B., F.C.W.</p><p id="P58">Validation M.C.G.</p><p id="P59">Formal analyses M.C.G., D.B., F.C.W.</p><p id="P60">Investigation M.C.G., D.B., M.K.B.</p><p id="P61">Resources</p><p id="P62">Data curation M.C.G.</p><p id="P63">Writing M.C.G., S.M.</p><p id="P64">Visualization</p><p id="P65">Supervision S.M.</p><p id="P66">Project administration S.M.</p><p id="P67">Funding acquisition S.M.</p></fn><fn id="FN3" fn-type="conflict"><p id="P68"><bold>Declaration Of Interests</bold></p><p id="P69">The authors declare no conflict of interests.</p></fn></fn-group><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Domínguez-Andrés</surname><given-names>J</given-names></name><name><surname>Barreiro</surname><given-names>LB</given-names></name><name><surname>Chavakis</surname><given-names>T</given-names></name><name><surname>Divangahi</surname><given-names>M</given-names></name><name><surname>Fuchs</surname><given-names>E</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>van der Meer</surname><given-names>JWM</given-names></name><name><surname>Mhlanga</surname><given-names>MM</given-names></name><name><surname>Mulder</surname><given-names>WJM</given-names></name><etal/></person-group><article-title>Defining trained immunity and its role in health and disease</article-title><source>Nat Rev Immunol</source><year>2020</year><pub-id pub-id-type="doi">10.1038/s41577-020-0285-6</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaufmann</surname><given-names>E</given-names></name><name><surname>Sanz</surname><given-names>J</given-names></name><name><surname>Dunn</surname><given-names>JL</given-names></name><name><surname>Khan</surname><given-names>N</given-names></name><name><surname>Mendonça</surname><given-names>LE</given-names></name><name><surname>Pacis</surname><given-names>A</given-names></name><name><surname>Tzelepis</surname><given-names>F</given-names></name><name><surname>Pernet</surname><given-names>E</given-names></name><name><surname>Dumaine</surname><given-names>A</given-names></name><name><surname>Grenier</surname><given-names>JC</given-names></name><etal/></person-group><article-title>BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis</article-title><source>Cell</source><year>2018</year><volume>172</volume><fpage>176</fpage><lpage>190</lpage><elocation-id>e19</elocation-id><pub-id pub-id-type="doi">10.1016/j.cell.2017.12.031</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moorlag</surname><given-names>SJCFM</given-names></name><name><surname>Khan</surname><given-names>N</given-names></name><name><surname>Novakovic</surname><given-names>B</given-names></name><name><surname>Kaufmann</surname><given-names>E</given-names></name><name><surname>Jansen</surname><given-names>T</given-names></name><name><surname>van Crevel</surname><given-names>R</given-names></name><name><surname>Divangahi</surname><given-names>M</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name></person-group><article-title>β-glucan induces protective trained immunity against Mycobacterium tuberculosis infection: a key role for IL-1</article-title><source>Cell Rep</source><year>2020</year><volume>31</volume><elocation-id>107634</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.107634</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bekkering</surname><given-names>S</given-names></name><name><surname>Arts</surname><given-names>RJW</given-names></name><name><surname>Novakovic</surname><given-names>B</given-names></name><name><surname>Kourtzelis</surname><given-names>I</given-names></name><name><surname>van der Heijden</surname><given-names>CDCC</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Popa</surname><given-names>CD</given-names></name><name><surname>ter Horst</surname><given-names>R</given-names></name><name><surname>van Tuijl</surname><given-names>J</given-names></name><name><surname>Netea-Maier</surname><given-names>RT</given-names></name><etal/></person-group><article-title>Metabolic induction of trained immunity through the mevalonate pathway</article-title><source>Cell</source><year>2018</year><volume>172</volume><fpage>135</fpage><lpage>146</lpage><elocation-id>e9</elocation-id><pub-id pub-id-type="doi">10.1016/j.cell.2017.11.025</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saeed</surname><given-names>S</given-names></name><name><surname>Quintin</surname><given-names>J</given-names></name><name><surname>Kerstens</surname><given-names>HHD</given-names></name><name><surname>Rao</surname><given-names>NA</given-names></name><name><surname>Aghajanirefah</surname><given-names>A</given-names></name><name><surname>Matarese</surname><given-names>F</given-names></name><name><surname>Cheng</surname><given-names>SC</given-names></name><name><surname>Ratter</surname><given-names>J</given-names></name><name><surname>Berentsem</surname><given-names>K</given-names></name><name><surname>Van Der Ent</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity</article-title><source>Science (80- )</source><year>2014</year><volume>345</volume><pub-id pub-id-type="doi">10.1126/science.1251086</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arts</surname><given-names>RJW</given-names></name><name><surname>Carvalho</surname><given-names>A</given-names></name><name><surname>La Rocca</surname><given-names>C</given-names></name><name><surname>Palma</surname><given-names>C</given-names></name><name><surname>Rodrigues</surname><given-names>F</given-names></name><name><surname>Silvestre</surname><given-names>R</given-names></name><name><surname>Kleinnijenhuis</surname><given-names>J</given-names></name><name><surname>Lachmandas</surname><given-names>E</given-names></name><name><surname>Gonçalves</surname><given-names>LG</given-names></name><name><surname>Belinha</surname><given-names>A</given-names></name><etal/></person-group><article-title>Immunometabolic pathways in BCG-induced trained immunity</article-title><source>Cell Rep</source><year>2016</year><volume>17</volume><fpage>2562</fpage><lpage>2571</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.11.011</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laval</surname><given-names>B</given-names></name><name><surname>de Maurizio</surname><given-names>J</given-names></name><name><surname>Kandalla</surname><given-names>PK</given-names></name><name><surname>Brisou</surname><given-names>G</given-names></name><name><surname>Simonnet</surname><given-names>L</given-names></name><name><surname>Huber</surname><given-names>C</given-names></name><name><surname>Gimenez</surname><given-names>G</given-names></name><name><surname>Matcovitch-Natan</surname><given-names>O</given-names></name><name><surname>Reinhardt</surname><given-names>S</given-names></name><name><surname>DAvid</surname><given-names>E</given-names></name><etal/></person-group><article-title>C/EBP-dependent epigenetic memory induces trained immunity in hematopoietic stem cells</article-title><source>Cell Stem Cell</source><year>2020</year><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2020.01.017</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christ</surname><given-names>A</given-names></name><name><surname>Günther</surname><given-names>P</given-names></name><name><surname>Lauterbach</surname><given-names>MAR</given-names></name><name><surname>Duewell</surname><given-names>P</given-names></name><name><surname>Biswas</surname><given-names>D</given-names></name><name><surname>Pelka</surname><given-names>K</given-names></name><name><surname>Scholz</surname><given-names>CJ</given-names></name><name><surname>Oosting</surname><given-names>M</given-names></name><name><surname>Haendler</surname><given-names>K</given-names></name><name><surname>Baβler</surname><given-names>K</given-names></name><etal/></person-group><article-title>Western diet triggers NLRP3-dependent innate immune reprogramming</article-title><source>Cell</source><year>2018</year><volume>172</volume><fpage>162</fpage><lpage>175</lpage><elocation-id>e14</elocation-id><pub-id pub-id-type="doi">10.1016/j.cell.2017.12.013</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bekkering</surname><given-names>S</given-names></name><name><surname>Blok</surname><given-names>BA</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Riksen</surname><given-names>NP</given-names></name><name><surname>Van Crevel</surname><given-names>R</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name></person-group><article-title>In vitro experimental model of trained innate immunity in human primary monocytes</article-title><source>Clin Vaccine Immunol</source><year>2016</year><volume>23</volume><fpage>926</fpage><lpage>933</lpage><pub-id pub-id-type="doi">10.1128/CVI.00349-16</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>van der Meer</surname><given-names>JWM</given-names></name></person-group><article-title>Trained Immunity: An Ancient Way of Remembering</article-title><source>Cell Host Microbe</source><year>2017</year><volume>21</volume><fpage>297</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2017.02.003</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Latz</surname><given-names>E</given-names></name><name><surname>Mills</surname><given-names>KHG</given-names></name><name><surname>Natoli</surname><given-names>G</given-names></name><name><surname>Stunnenberg</surname><given-names>HG</given-names></name><name><surname>O’Neill</surname><given-names>LAJ</given-names></name><name><surname>Xavier</surname><given-names>RJ</given-names></name></person-group><article-title>Trained immunity: A program of innate immune memory in health and disease</article-title><source>Science (80- )</source><year>2016</year><volume>352</volume><elocation-id>aaf1098</elocation-id><pub-id pub-id-type="doi">10.1126/science.aaf1098</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>JC</given-names></name><name><surname>Madera</surname><given-names>S</given-names></name><name><surname>Bezman</surname><given-names>NA</given-names></name><name><surname>Beilke</surname><given-names>JN</given-names></name><name><surname>Kaplan</surname><given-names>MH</given-names></name><name><surname>Lanier</surname><given-names>LL</given-names></name></person-group><article-title>Proinflammatory cytokine signaling required for the generation of natural killer cell memory</article-title><source>J Exp Med</source><year>2012</year><volume>209</volume><fpage>947</fpage><lpage>954</lpage><pub-id pub-id-type="doi">10.1084/jem.20111760</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Leary</surname><given-names>JG</given-names></name><name><surname>Goodarzi</surname><given-names>M</given-names></name><name><surname>Drayton</surname><given-names>DL</given-names></name><name><surname>von Andrian</surname><given-names>UH</given-names></name></person-group><article-title>T cell-and B cell-independent adaptive immunity mediated by natural killer cells</article-title><source>Nat Immunol</source><year>2006</year><volume>7</volume><fpage>507</fpage><lpage>516</lpage><pub-id pub-id-type="doi">10.1038/ni1332</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kleinnijenhuis</surname><given-names>J</given-names></name><name><surname>Quintin</surname><given-names>J</given-names></name><name><surname>Preijers</surname><given-names>F</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Jacobs</surname><given-names>C</given-names></name><name><surname>Xavier</surname><given-names>RJ</given-names></name><name><surname>van der Meer</surname><given-names>JWM</given-names></name><name><surname>van Crevel</surname><given-names>R</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name></person-group><article-title>BCG-induced trained immunity in NK cells: Role for non-specific protection to infection</article-title><source>Clin Immunol</source><year>2014</year><volume>155</volume><fpage>213</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.1016/j.clim.2014.10.005</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sohrabi</surname><given-names>Y</given-names></name><name><surname>Lagache</surname><given-names>SMM</given-names></name><name><surname>Voges</surname><given-names>VC</given-names></name><name><surname>Semo</surname><given-names>D</given-names></name><name><surname>Sonntag</surname><given-names>G</given-names></name><name><surname>Hanemann</surname><given-names>I</given-names></name><name><surname>Kahles</surname><given-names>F</given-names></name><name><surname>Walten berger</surname><given-names>J</given-names></name><name><surname>Findeisen</surname><given-names>HM</given-names></name></person-group><article-title>OxLDL-mediated immunologic memory in endothelial cells</article-title><source>J Mol Cell Cardiol</source><year>2020</year><volume>146</volume><fpage>121</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2020.07.006</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naik</surname><given-names>S</given-names></name><name><surname>Larsen</surname><given-names>SB</given-names></name><name><surname>Gomez</surname><given-names>NC</given-names></name><name><surname>Alaverdyan</surname><given-names>K</given-names></name><name><surname>Sendoel</surname><given-names>A</given-names></name><name><surname>Yuan</surname><given-names>S</given-names></name><name><surname>Polak</surname><given-names>L</given-names></name><name><surname>Kulukian</surname><given-names>A</given-names></name><name><surname>Chai</surname><given-names>S</given-names></name><name><surname>Fuchs</surname><given-names>E</given-names></name></person-group><article-title>Inflammatory memory sensitizes skin epithelial stem cells to tissue damage</article-title><source>Nature</source><year>2017</year><volume>550</volume><fpage>475</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1038/nature24271</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moorlag</surname><given-names>SJCFM</given-names></name><name><surname>Rodriguez-Rosales</surname><given-names>YA</given-names></name><name><surname>Gillard</surname><given-names>J</given-names></name><name><surname>Fanucchi</surname><given-names>S</given-names></name><name><surname>Theunissen</surname><given-names>K</given-names></name><name><surname>Novakovic</surname><given-names>B</given-names></name><name><surname>de Bont</surname><given-names>CM</given-names></name><name><surname>Negishi</surname><given-names>Y</given-names></name><name><surname>Fok</surname><given-names>ET</given-names></name><name><surname>Kalafati</surname><given-names>L</given-names></name><etal/></person-group><article-title>BCG vaccination induces long-term functional reprogramming of human neutrophils</article-title><source>Cell Rep</source><year>2020</year><volume>33</volume><elocation-id>108387</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.108387</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalafati</surname><given-names>L</given-names></name><name><surname>Kourtzelis</surname><given-names>I</given-names></name><name><surname>Schulte-Schrepping</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Hatzioannou</surname><given-names>A</given-names></name><name><surname>Grinenko</surname><given-names>T</given-names></name><name><surname>Hagag</surname><given-names>E</given-names></name><name><surname>Sinha</surname><given-names>A</given-names></name><name><surname>Has</surname><given-names>C</given-names></name><name><surname>Dietz</surname><given-names>S</given-names></name><etal/></person-group><article-title>Innate immune training of granulopoiesis promotes anti-tumor activity</article-title><source>Cell</source><year>2020</year><volume>183</volume><fpage>771</fpage><lpage>785</lpage><elocation-id>e12</elocation-id><pub-id pub-id-type="doi">10.1016/j.cell.2020.09.058</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomes</surname><given-names>MC</given-names></name><name><surname>Mostowy</surname><given-names>S</given-names></name></person-group><article-title>The case for modeling human infection in zebrafish</article-title><source>Trends Microbiol</source><year>2020</year><volume>28</volume><fpage>10</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2019.08.005</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torraca</surname><given-names>V</given-names></name><name><surname>Mostowy</surname><given-names>S</given-names></name></person-group><article-title>Zebrafish infection: from pathogenesis to cell biology</article-title><source>Trends Cell Biol</source><year>2018</year><volume>28</volume><fpage>143</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2017.10.002</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stream</surname><given-names>A</given-names></name><name><surname>Madigan</surname><given-names>CA</given-names></name></person-group><article-title>Zebrafish: an underutilized tool for discovery in host–microbe interactions</article-title><source>Trends Immunol</source><year>2022</year><volume>43</volume><fpage>426</fpage><lpage>437</lpage><pub-id pub-id-type="doi">10.1016/j.it.2022.03.011</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Roper</surname><given-names>C</given-names></name><name><surname>Tanguay</surname><given-names>RL</given-names></name></person-group><chapter-title>Zebrafish as a model for developmental biology and toxicology</chapter-title><source>Handbook of Developmental Neurotoxicology</source><publisher-name>Academic Press</publisher-name><year>2018</year><fpage>143</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1016/b978-0-12-809405-1.00012-2</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Page</surname><given-names>DM</given-names></name><name><surname>Wittamer</surname><given-names>V</given-names></name><name><surname>Bertrand</surname><given-names>JY</given-names></name><name><surname>Lewis</surname><given-names>KL</given-names></name><name><surname>Pratt</surname><given-names>DN</given-names></name><name><surname>Delgado</surname><given-names>N</given-names></name><name><surname>Schale</surname><given-names>SE</given-names></name><name><surname>McGue</surname><given-names>C</given-names></name><name><surname>Jacobsen</surname><given-names>BH</given-names></name><name><surname>Doty</surname><given-names>A</given-names></name><etal/></person-group><article-title>An evolutionarily conserved program of B-cell development and activation in zebrafish</article-title><source>Blood</source><year>2013</year><volume>122</volume><fpage>e1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1182/blood-2012-12-471029</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>SH</given-names></name><name><surname>Chua</surname><given-names>HL</given-names></name><name><surname>Gong</surname><given-names>Z</given-names></name><name><surname>Lam</surname><given-names>TJ</given-names></name><name><surname>Sin</surname><given-names>YM</given-names></name></person-group><article-title>Development and maturation of the immune system in zebrafish, Danio rerio: A gene expression profiling, in situ hybridization and immunological study</article-title><source>Dev Comp Immunol</source><year>2004</year><volume>28</volume><fpage>9</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/S0145-305X(03)00103-4</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howe</surname><given-names>K</given-names></name><name><surname>Clark</surname><given-names>MD</given-names></name><name><surname>Torroja</surname><given-names>CF</given-names></name><name><surname>Torrance</surname><given-names>J</given-names></name><name><surname>Berthelot</surname><given-names>C</given-names></name><name><surname>Muffato</surname><given-names>M</given-names></name><name><surname>Collins</surname><given-names>JE</given-names></name><name><surname>Humphray</surname><given-names>S</given-names></name><name><surname>McLaren</surname><given-names>K</given-names></name><name><surname>Matthews</surname><given-names>L</given-names></name><etal/></person-group><article-title>The zebrafish reference genome sequence and its relationship to the human genome</article-title><source>Nature</source><year>2013</year><volume>496</volume><fpage>498</fpage><lpage>503</lpage><pub-id pub-id-type="doi">10.1038/nature12111</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Cui</surname><given-names>G</given-names></name><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Ai</surname><given-names>D</given-names></name><name><surname>Gao</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Suo</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Lv</surname><given-names>P</given-names></name><etal/></person-group><article-title>A 3D atlas of hematopoietic stem and progenitor cell expansion by multi-dimensional RNA-seq analysis</article-title><source>Cell Rep</source><year>2019</year><volume>27</volume><fpage>1567</fpage><lpage>1578</lpage><elocation-id>e5</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2019.04.030</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goessling</surname><given-names>W</given-names></name><name><surname>North</surname><given-names>TE</given-names></name></person-group><article-title>Hematopoietic stem cell development: using the zebrafish to identify the signaling networks and physical forces regulating hematopoiesis</article-title><source>Methods Cell Biol</source><year>2011</year><volume>105</volume><fpage>117</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-381320-6.00005-9</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frame</surname><given-names>JM</given-names></name><name><surname>Kubaczka</surname><given-names>C</given-names></name><name><surname>Long</surname><given-names>TL</given-names></name><name><surname>Esain</surname><given-names>V</given-names></name><name><surname>Soto</surname><given-names>RA</given-names></name><name><surname>Hachimi</surname><given-names>M</given-names></name><name><surname>Jing</surname><given-names>R</given-names></name><name><surname>Shwartz</surname><given-names>A</given-names></name><name><surname>Goessling</surname><given-names>W</given-names></name><name><surname>Daley</surname><given-names>GQ</given-names></name><etal/></person-group><article-title>Metabolic regulation of inflammasome activity controls embryonic hematopoietic stem and progenitor cell production</article-title><source>Dev Cell</source><year>2020</year><volume>55</volume><fpage>133</fpage><lpage>149</lpage><elocation-id>e6</elocation-id><pub-id pub-id-type="doi">10.1016/J.DEVCEL.2020.07.015</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>CJ</given-names></name><name><surname>Flores</surname><given-names>MV</given-names></name><name><surname>Oehlers</surname><given-names>SH</given-names></name><name><surname>Sanderson</surname><given-names>LE</given-names></name><name><surname>Lam</surname><given-names>EY</given-names></name><name><surname>Crosier</surname><given-names>KE</given-names></name><name><surname>Crosier</surname><given-names>PS</given-names></name></person-group><article-title>Infection-responsive expansion of the hematopoietic stem and progenitor cell compartment in zebrafish is dependent upon inducible nitric oxide</article-title><source>Stem Cell</source><year>2012</year><volume>10</volume><fpage>198</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2012.01.007</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Espín-Palazón</surname><given-names>R</given-names></name><name><surname>Stachura</surname><given-names>DL</given-names></name><name><surname>Campbell</surname><given-names>CA</given-names></name><name><surname>García-Moreno</surname><given-names>D</given-names></name><name><surname>Del Cid</surname><given-names>N</given-names></name><name><surname>Kim</surname><given-names>AD</given-names></name><name><surname>Candel</surname><given-names>S</given-names></name><name><surname>Meseguer</surname><given-names>J</given-names></name><name><surname>Mulero</surname><given-names>V</given-names></name><name><surname>Traver</surname><given-names>D</given-names></name></person-group><article-title>Proinflammatory signaling regulates hematopoietic stem cell emergence</article-title><source>Cell</source><year>2014</year><volume>159</volume><fpage>1070</fpage><lpage>1085</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.10.031</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herbomel</surname><given-names>P</given-names></name><name><surname>Thisse</surname><given-names>B</given-names></name><name><surname>Thisse</surname><given-names>C</given-names></name></person-group><article-title>Ontogeny and behaviour of early macrophages in the zebrafish embryo</article-title><source>Development</source><year>1999</year><volume>126</volume><fpage>3735</fpage><lpage>3745</lpage></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernández</surname><given-names>PP</given-names></name><name><surname>Strzelecka</surname><given-names>PM</given-names></name><name><surname>Athanasiadis</surname><given-names>EI</given-names></name><name><surname>Hall</surname><given-names>D</given-names></name><name><surname>Robalo</surname><given-names>AF</given-names></name><name><surname>Collins</surname><given-names>CM</given-names></name><name><surname>Boudinot</surname><given-names>P</given-names></name><name><surname>Levraud</surname><given-names>J-P</given-names></name><name><surname>Cvejic</surname><given-names>A</given-names></name></person-group><article-title>Single-cell transcriptional analysis reveals ILC-like cells in zebrafish</article-title><source>Sci Immunol</source><year>2018</year><fpage>3</fpage></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rojo-Cebreros</surname><given-names>AH</given-names></name><name><surname>Ibarra-Castro</surname><given-names>L</given-names></name><name><surname>Martínez-Brown</surname><given-names>JM</given-names></name></person-group><article-title>Immunostimulation and trained immunity in marine fish larvae</article-title><source>Fish Shellfish Immunol</source><year>2018</year><volume>80</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1016/j.fsi.2018.05.044</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Chi</surname><given-names>H</given-names></name><name><surname>Dalmo</surname><given-names>RA</given-names></name></person-group><article-title>Trained innate immunity of fish is a viable approach in larval aquaculture</article-title><source>Front Immunol</source><year>2019</year><volume>10</volume><elocation-id>42</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2019.00042</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petit</surname><given-names>J</given-names></name><name><surname>Embregts</surname><given-names>CWE</given-names></name><name><surname>Forlenza</surname><given-names>M</given-names></name><name><surname>Wiegertjes</surname><given-names>GF</given-names></name></person-group><article-title>Evidence of trained immunity in a fish: conserved features in carp macrophages</article-title><source>J Immunol</source><year>2019</year><volume>203</volume><elocation-id>ji1900137</elocation-id><pub-id pub-id-type="doi">10.4049/jimmunol.1900137</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oksanen</surname><given-names>KE</given-names></name><name><surname>Myllymäki</surname><given-names>H</given-names></name><name><surname>Ahava</surname><given-names>MJ</given-names></name><name><surname>Mäkinen</surname><given-names>L</given-names></name><name><surname>Parikka</surname><given-names>M</given-names></name><name><surname>Rämet</surname><given-names>M</given-names></name></person-group><article-title>DNA vaccination boosts Bacillus Calmette-Guérin protection against mycobacterial infection in zebrafish</article-title><source>Dev Comp Immunol</source><year>2016</year><volume>54</volume><fpage>89</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1016/j.dci.2015.09.001</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sommerset</surname><given-names>I</given-names></name><name><surname>Lorenzen</surname><given-names>E</given-names></name><name><surname>Lorenzen</surname><given-names>N</given-names></name><name><surname>Bleie</surname><given-names>H</given-names></name><name><surname>Nerland</surname><given-names>AH</given-names></name></person-group><article-title>A DNA vaccine directed against a rainbow trout rhabdovirus induces early protection against a nodavirus challenge in turbot</article-title><source>Vaccine</source><year>2003</year><volume>21</volume><fpage>4661</fpage><lpage>4667</lpage><pub-id pub-id-type="doi">10.1016/S0264-410X(03)00526-7</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez-Lopez</surname><given-names>A</given-names></name><name><surname>Garcia-Valtanen</surname><given-names>P</given-names></name><name><surname>Ortega-Villaizan</surname><given-names>M</given-names></name><name><surname>Chico</surname><given-names>V</given-names></name><name><surname>Gomez-Casado</surname><given-names>E</given-names></name><name><surname>Coll</surname><given-names>JM</given-names></name><name><surname>Estepa</surname><given-names>A</given-names></name></person-group><article-title>VHSV G glycoprotein major determinants implicated in triggering the host type I IFN antiviral response as DNA vaccine molecular adjuvants</article-title><source>Vaccine</source><year>2014</year><volume>32</volume><fpage>6012</fpage><lpage>6019</lpage><pub-id pub-id-type="doi">10.1016/J.VACCINE.2014.07.111</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darroch</surname><given-names>H</given-names></name><name><surname>Astin</surname><given-names>JW</given-names></name><name><surname>Hall</surname><given-names>CJ</given-names></name></person-group><article-title>Towards a new model of trained immunity: Exposure to bacteria and β-glucan protects larval zebrafish against subsequent infections</article-title><source>Dev Comp Immunol</source><year>2022</year><volume>132</volume><elocation-id>104400</elocation-id><pub-id pub-id-type="doi">10.1016/j.dci.2022.104400</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willis</surname><given-names>AR</given-names></name><name><surname>Torraca</surname><given-names>V</given-names></name><name><surname>Gomes</surname><given-names>MC</given-names></name><name><surname>Shelley</surname><given-names>J</given-names></name><name><surname>Mazon-Moya</surname><given-names>M</given-names></name><name><surname>Filloux</surname><given-names>A</given-names></name><name><surname>Lo Celso</surname><given-names>C</given-names></name><name><surname>Mostowy</surname><given-names>S</given-names></name></person-group><article-title>Shigella-induced emergency granulopoiesis protects zebrafish larvae from secondary infection</article-title><source>MBio</source><year>2018</year><volume>9</volume><elocation-id>e00933-18</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.00933-18</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tacconelli</surname><given-names>E</given-names></name><name><surname>Carrara</surname><given-names>E</given-names></name><name><surname>Savoldi</surname><given-names>A</given-names></name><name><surname>Harbarth</surname><given-names>S</given-names></name><name><surname>Mendelson</surname><given-names>M</given-names></name><name><surname>Monnet</surname><given-names>DL</given-names></name><name><surname>Pulcini</surname><given-names>C</given-names></name><name><surname>Kahlmeter</surname><given-names>G</given-names></name><name><surname>Kluytmans</surname><given-names>J</given-names></name><name><surname>Carmeli</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Discovery, research, and development of new antibiotics: the WHO priority list of antibioticresistant bacteria and tuberculosis</article-title><source>Lancet Infect Dis</source><year>2018</year><volume>18</volume><fpage>318</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(17)30753-3</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kotloff</surname><given-names>KL</given-names></name><name><surname>Riddle</surname><given-names>MS</given-names></name><name><surname>Platts-Mills</surname><given-names>JA</given-names></name><name><surname>Pavlinac</surname><given-names>P</given-names></name><name><surname>Zaidi</surname><given-names>AKM</given-names></name></person-group><source>Shigellosis Lancet</source><year>2018</year><volume>391</volume><fpage>801</fpage><lpage>812</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(17)33296-8</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schnupf</surname><given-names>P</given-names></name><name><surname>Sansonetti</surname><given-names>PJ</given-names></name></person-group><article-title>Shigella pathogenesis: new insights through advanced methodologies</article-title><source>Microbiol Spectr</source><year>2019</year><volume>7</volume><pub-id pub-id-type="doi">10.1128/microbiolspec.bai-0023-2019</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashida</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>M</given-names></name><name><surname>Sasakawa</surname><given-names>C</given-names></name></person-group><article-title>Manipulation of the host cell death pathway by Shigella</article-title><source>Cell Microbiol</source><year>2014</year><volume>16</volume><fpage>1757</fpage><lpage>1766</lpage><pub-id pub-id-type="doi">10.1111/cmi.12367</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mostowy</surname><given-names>S</given-names></name><name><surname>Boucontet</surname><given-names>L</given-names></name><name><surname>Mazon Moya</surname><given-names>MJ</given-names></name><name><surname>Sirianni</surname><given-names>A</given-names></name><name><surname>Boudinot</surname><given-names>P</given-names></name><name><surname>Hollinshead</surname><given-names>M</given-names></name><name><surname>Cossart</surname><given-names>P</given-names></name><name><surname>Herbomel</surname><given-names>P</given-names></name><name><surname>Levraud</surname><given-names>JP</given-names></name><name><surname>Colucci-Guyon</surname><given-names>E</given-names></name></person-group><article-title>The zebrafish as a new model for the in vivo study of Shigella flexneri interaction with phagocytes and bacterial autophagy</article-title><source>PLoS Pathog</source><year>2013</year><volume>9</volume><elocation-id>e1003588</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003588</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duggan</surname><given-names>GM</given-names></name><name><surname>Mostowy</surname><given-names>S</given-names></name></person-group><article-title>Use of zebrafish to study Shigella infection</article-title><source>Dis Model Mech</source><year>2018</year><volume>11</volume><elocation-id>dmm032151</elocation-id><pub-id pub-id-type="doi">10.1242/dmm.032151</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazon-Moya</surname><given-names>MJ</given-names></name><name><surname>Willis</surname><given-names>AR</given-names></name><name><surname>Torraca</surname><given-names>V</given-names></name><name><surname>Boucontet</surname><given-names>L</given-names></name><name><surname>Shenoy</surname><given-names>AR</given-names></name><name><surname>Colucci-Guyon</surname><given-names>E</given-names></name><name><surname>Mostowy</surname><given-names>S</given-names></name><name><surname>Philpott</surname><given-names>DJ</given-names></name></person-group><article-title>Septins restrict inflammation and protect zebrafish larvae from Shigella infection</article-title><source>PLoS Pathog</source><year>2017</year><volume>13</volume><elocation-id>e1006467</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1006467</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Ngo</surname><given-names>H</given-names></name><name><surname>Robertin</surname><given-names>S</given-names></name><name><surname>Brokatzky</surname><given-names>D</given-names></name><name><surname>Bielecka</surname><given-names>MK</given-names></name><name><surname>Lobato-Márquez</surname><given-names>D</given-names></name><name><surname>Torraca</surname><given-names>V</given-names></name><name><surname>Mostowy</surname><given-names>S</given-names></name></person-group><article-title>Septins promote caspase activity and coordinate mitochondrial apoptosis</article-title><source>Cytoskeleton</source><year>2022</year><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1002/cm.21696</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torraca</surname><given-names>V</given-names></name><name><surname>Kaforou</surname><given-names>M</given-names></name><name><surname>Watson</surname><given-names>J</given-names></name><name><surname>Duggan</surname><given-names>GM</given-names></name><name><surname>Guerrero-Gutierrez</surname><given-names>H</given-names></name><name><surname>Krokowski</surname><given-names>S</given-names></name><name><surname>Hollinshead</surname><given-names>M</given-names></name><name><surname>Clarke</surname><given-names>TB</given-names></name><name><surname>Mostowy</surname><given-names>RJ</given-names></name><name><surname>Tomlinson</surname><given-names>GS</given-names></name><etal/></person-group><article-title>Shigella sonnei infection of zebrafish reveals that O-antigen mediates neutrophil tolerance and dysentery incidence</article-title><source>PLoS Pathog</source><year>2019</year><volume>15</volume><pub-id pub-id-type="doi">10.1371/journal.ppat.1008006</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cirovic</surname><given-names>B</given-names></name><name><surname>Bree</surname><given-names>LCJ</given-names></name><name><surname>De Groh</surname><given-names>L</given-names></name><name><surname>Curtis</surname><given-names>N</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Schlitzer</surname><given-names>A</given-names></name></person-group><article-title>BCG vaccination in humans elicits trained immunity via the hematopoietic progenitor compartment</article-title><source>Cell Host Microbe</source><year>2020</year><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2020.05.014</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitroulis</surname><given-names>I</given-names></name><name><surname>Ruppova</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>LS</given-names></name><name><surname>Grzybek</surname><given-names>M</given-names></name><name><surname>Grinenko</surname><given-names>T</given-names></name><name><surname>Eugster</surname><given-names>A</given-names></name><name><surname>Troullinaki</surname><given-names>M</given-names></name><name><surname>Palladini</surname><given-names>A</given-names></name><name><surname>Kourtzelis</surname><given-names>I</given-names></name><etal/></person-group><article-title>Modulation of myelopoiesis progenitors is an integral component of trained immunity</article-title><source>Cell</source><year>2018</year><volume>172</volume><fpage>147</fpage><lpage>161</lpage><elocation-id>e12</elocation-id><pub-id pub-id-type="doi">10.1016/j.cell.2017.11.034</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kleinnijenhuis</surname><given-names>J</given-names></name><name><surname>Quintin</surname><given-names>J</given-names></name><name><surname>Preijers</surname><given-names>F</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Ifrim</surname><given-names>DC</given-names></name><name><surname>Saeed</surname><given-names>S</given-names></name><name><surname>Jacobs</surname><given-names>C</given-names></name><name><surname>Van Loenhout</surname><given-names>J</given-names></name><name><surname>De Jong</surname><given-names>D</given-names></name><name><surname>Hendrik</surname><given-names>S</given-names></name><etal/></person-group><article-title>Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes</article-title><source>Proc Natl Acad Sci U S A</source><year>2012</year><volume>109</volume><fpage>17537</fpage><lpage>17542</lpage><pub-id pub-id-type="doi">10.1073/pnas.1202870109</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quintin</surname><given-names>J</given-names></name><name><surname>Saeed</surname><given-names>S</given-names></name><name><surname>Martens</surname><given-names>JHA</given-names></name><name><surname>Giamarellos-Bourboulis</surname><given-names>EJ</given-names></name><name><surname>Ifrim</surname><given-names>DC</given-names></name><name><surname>Logie</surname><given-names>C</given-names></name><name><surname>Jacobs</surname><given-names>L</given-names></name><name><surname>Jansen</surname><given-names>T</given-names></name><name><surname>Kullberg</surname><given-names>BJ</given-names></name><name><surname>Wijmenga</surname><given-names>C</given-names></name><etal/></person-group><article-title>Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes</article-title><source>Cell Host Microbe</source><year>2012</year><volume>12</volume><fpage>223</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2012.06.006</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arts</surname><given-names>RJW</given-names></name><name><surname>Blok</surname><given-names>BA</given-names></name><name><surname>Aaby</surname><given-names>P</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>de Jong</surname><given-names>D</given-names></name><name><surname>van der Meer</surname><given-names>JWM</given-names></name><name><surname>Benn</surname><given-names>CS</given-names></name><name><surname>van Crevel</surname><given-names>R</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name></person-group><article-title>Long-term in vitro and in vivo effects of γ-irradiated BCG on innate and adaptive immunity</article-title><source>J Leukoc Biol</source><year>2015</year><volume>98</volume><fpage>995</fpage><lpage>1001</lpage><pub-id pub-id-type="doi">10.1189/jlb.4ma0215-059r</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juste</surname><given-names>RA</given-names></name><name><surname>Ferreras-Colino</surname><given-names>E</given-names></name><name><surname>de la Fuente</surname><given-names>J</given-names></name><name><surname>Domínguez</surname><given-names>M</given-names></name><name><surname>Risalde</surname><given-names>MA</given-names></name><name><surname>Domínguez</surname><given-names>L</given-names></name><name><surname>Cabezas-Cruz</surname><given-names>A</given-names></name><name><surname>Gortázar</surname><given-names>C</given-names></name></person-group><article-title>Heat inactivated mycobacteria, alpha-Gal and zebrafish: Insights gained from experiences with two promising trained immunity inductors and a validated animal model</article-title><source>Immunology</source><year>2022</year><pub-id pub-id-type="doi">10.1111/imm.13529</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lobato-Márquez</surname><given-names>D</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Güler</surname><given-names>GÖ</given-names></name><name><surname>Ojiakor</surname><given-names>A</given-names></name><name><surname>Pilhofer</surname><given-names>M</given-names></name><name><surname>Mostowy</surname><given-names>S</given-names></name></person-group><article-title>Mechanistic insight into bacterial entrapment by septin cage reconstitution</article-title><source>Nat Commun</source><year>2021</year><volume>12</volume><pub-id pub-id-type="doi">10.1038/s41467-021-24721-5</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kane</surname><given-names>CD</given-names></name><name><surname>Schuch</surname><given-names>R</given-names></name><name><surname>Day</surname><given-names>WA</given-names></name><name><surname>Maurelli</surname><given-names>AT</given-names></name></person-group><article-title>MxiE regulates intracellular expression of factors secreted by the Shigella flexneri 2a type III secretion system</article-title><source>J Bacteriol</source><year>2002</year><volume>184</volume><fpage>4409</fpage><lpage>4419</lpage><pub-id pub-id-type="doi">10.1128/JB.184.16.4409-4419.2002</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arbibe</surname><given-names>L</given-names></name><name><surname>Kim</surname><given-names>DW</given-names></name><name><surname>Batsche</surname><given-names>E</given-names></name><name><surname>Pedron</surname><given-names>T</given-names></name><name><surname>Mateescu</surname><given-names>B</given-names></name><name><surname>Muchardt</surname><given-names>C</given-names></name><name><surname>Parsot</surname><given-names>C</given-names></name><name><surname>Sansonetti</surname><given-names>PJ</given-names></name></person-group><article-title>An injected bacterial effector targets chromatin access for transcription factor NF-ĸB to alter transcription of host genes involved in immune responses</article-title><source>Nat Immunol</source><year>2007</year><volume>8</volume><fpage>47</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1038/ni1423</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashida</surname><given-names>H</given-names></name><name><surname>Sasakawa</surname><given-names>C</given-names></name></person-group><article-title>Shigella hacks host immune responses by reprogramming the host epigenome</article-title><source>EMBO J</source><year>2014</year><volume>33</volume><fpage>2598</fpage><lpage>2600</lpage><pub-id pub-id-type="doi">10.15252/embj.201489934</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reiterer</surname><given-names>V</given-names></name><name><surname>Grossniklaus</surname><given-names>L</given-names></name><name><surname>Tschon</surname><given-names>T</given-names></name><name><surname>Kasper</surname><given-names>CA</given-names></name><name><surname>Sorg</surname><given-names>I</given-names></name><name><surname>Arrieumerlou</surname><given-names>C</given-names></name></person-group><article-title>Shigella flexneri type III secreted effector OspF reveals new crosstalks of proinflammatory signaling pathways during bacterial infection</article-title><source>Cell Signal</source><year>2011</year><volume>23</volume><fpage>1188</fpage><lpage>1196</lpage><pub-id pub-id-type="doi">10.1016/j.cellsig.2011.03.006</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kröller-Schön</surname><given-names>S</given-names></name><name><surname>Steven</surname><given-names>S</given-names></name><name><surname>Kossmann</surname><given-names>S</given-names></name><name><surname>Scholz</surname><given-names>A</given-names></name><name><surname>Daub</surname><given-names>S</given-names></name><name><surname>Oelze</surname><given-names>M</given-names></name><name><surname>Xia</surname><given-names>N</given-names></name><name><surname>Hausding</surname><given-names>M</given-names></name><name><surname>Mikhed</surname><given-names>Y</given-names></name><name><surname>Zinβius</surname><given-names>E</given-names></name><etal/></person-group><article-title>Molecular mechanisms of the crosstalk between mitochondria and NADPH oxidase through reactive oxygen species-Studies in white blood cells and in animal models</article-title><source>Antioxidants Redox Signal</source><year>2014</year><volume>20</volume><fpage>247</fpage><lpage>266</lpage><pub-id pub-id-type="doi">10.1089/ars.2012.4953</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brokatzky</surname><given-names>D</given-names></name><name><surname>Mostowy</surname><given-names>S</given-names></name></person-group><article-title>Pyroptosis in host defence against bacterial infection</article-title><source>DMM Dis Model Mech</source><year>2022</year><volume>15</volume><pub-id pub-id-type="doi">10.1242/dmm.049414</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kleinnijenhuis</surname><given-names>J</given-names></name><name><surname>Quintin</surname><given-names>J</given-names></name><name><surname>Preijers</surname><given-names>F</given-names></name><name><surname>Benn</surname><given-names>CS</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Jacobs</surname><given-names>C</given-names></name><name><surname>Van Loenhout</surname><given-names>J</given-names></name><name><surname>Xavier</surname><given-names>RJ</given-names></name><name><surname>Aaby</surname><given-names>P</given-names></name><name><surname>Van Der Meer</surname><given-names>JWM</given-names></name><etal/></person-group><article-title>Long-lasting effects of BCG vaccination on both heterologous TH1/TH17 responses and innate trained immunity</article-title><source>J Innate Immun</source><year>2014</year><volume>6</volume><fpage>152</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1159/000355628</pub-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname><given-names>L</given-names></name><name><surname>Cords</surname><given-names>O</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Acuna-Villaorduna</surname><given-names>C</given-names></name><name><surname>Bonnet</surname><given-names>M</given-names></name><name><surname>Fox</surname><given-names>GJ</given-names></name><name><surname>Carvalho</surname><given-names>ACC</given-names></name><name><surname>Chan</surname><given-names>PC</given-names></name><name><surname>Croda</surname><given-names>J</given-names></name><name><surname>Hill</surname><given-names>PC</given-names></name><etal/></person-group><article-title>Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis</article-title><source>Lancet Glob Heal</source><year>2022</year><volume>10</volume><fpage>e1307</fpage><lpage>e1316</lpage><pub-id pub-id-type="doi">10.1016/S2214-109X(22)00283-2</pub-id></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katzmarski</surname><given-names>N</given-names></name><name><surname>Domínguez-Andrés</surname><given-names>J</given-names></name><name><surname>Cirovic</surname><given-names>B</given-names></name><name><surname>Renieris</surname><given-names>G</given-names></name><name><surname>Ciarlo</surname><given-names>E</given-names></name><name><surname>Le Roy</surname><given-names>D</given-names></name><name><surname>Lepikhov</surname><given-names>K</given-names></name><name><surname>Kattler</surname><given-names>K</given-names></name><name><surname>Gasparoni</surname><given-names>G</given-names></name><name><surname>Händler</surname><given-names>K</given-names></name><etal/></person-group><article-title>Transmission of trained immunity and heterologous resistance to infections across generations</article-title><source>Nat Immunol</source><year>2021</year><volume>22</volume><fpage>1382</fpage><lpage>1390</lpage><pub-id pub-id-type="doi">10.1038/s41590-021-01052-7</pub-id></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaufmann</surname><given-names>E</given-names></name><name><surname>Landekic</surname><given-names>M</given-names></name><name><surname>Downey</surname><given-names>J</given-names></name><name><surname>Chronopoulos</surname><given-names>J</given-names></name><name><surname>Teimouri Nezhad</surname><given-names>S</given-names></name><name><surname>Tran</surname><given-names>K</given-names></name><name><surname>Vinh</surname><given-names>DC</given-names></name><name><surname>Barreiro</surname><given-names>LB</given-names></name><name><surname>Divangahi</surname><given-names>M</given-names></name></person-group><article-title>Lack of evidence for intergenerational inheritance of immune resistance to infections</article-title><source>Nat Immunol</source><year>2022</year><volume>23</volume><fpage>203</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1038/s41590-021-01102-0</pub-id></element-citation></ref><ref id="R67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katzmarski</surname><given-names>N</given-names></name><name><surname>Domínguez-Andrés</surname><given-names>J</given-names></name><name><surname>Cirovic</surname><given-names>B</given-names></name><name><surname>Renieris</surname><given-names>G</given-names></name><name><surname>Ciarlo</surname><given-names>E</given-names></name><name><surname>Le Roy</surname><given-names>D</given-names></name><name><surname>Lepikhov</surname><given-names>K</given-names></name><name><surname>Kattler</surname><given-names>K</given-names></name><name><surname>Gasparoni</surname><given-names>G</given-names></name><name><surname>Händler</surname><given-names>K</given-names></name><etal/></person-group><article-title>Reply to: ‘Lack of evidence for intergenerational inheritance of immune resistance to infections’</article-title><source>Nat Immunol</source><year>2022</year><volume>23</volume><fpage>208</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1038/s41590-021-01103-z</pub-id></element-citation></ref><ref id="R68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crim</surname><given-names>MJ</given-names></name><name><surname>Lawrence</surname><given-names>C</given-names></name></person-group><article-title>A fish is not a mouse: understanding differences in background genetics is critical for reproducibility</article-title><source>Lab Anim (NY)</source><year>2021</year><volume>50</volume><fpage>19</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1038/s41684-020-00683-x</pub-id></element-citation></ref><ref id="R69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Moorlag</surname><given-names>SJCFM</given-names></name><name><surname>Domínguez-Andrés</surname><given-names>J</given-names></name><name><surname>Bulut</surname><given-names>Ö</given-names></name><name><surname>Kilic</surname><given-names>G</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>van Crevel</surname><given-names>R</given-names></name><name><surname>Xu</surname><given-names>C-J</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><etal/></person-group><article-title>Single-cell RNA sequencing reveals induction of distinct trained immunity programs in human monocytes</article-title><source>J Clin Invest</source><year>2022</year><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1172/jci147719</pub-id></element-citation></ref><ref id="R70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunham-Snary</surname><given-names>KJ</given-names></name><name><surname>Surewaard</surname><given-names>BG</given-names></name><name><surname>Mewburn</surname><given-names>JD</given-names></name><name><surname>Bentley</surname><given-names>RE</given-names></name><name><surname>Martin</surname><given-names>AY</given-names></name><name><surname>Jones</surname><given-names>O</given-names></name><name><surname>Al-Qazazi</surname><given-names>R</given-names></name><name><surname>Lima</surname><given-names>PA</given-names></name><name><surname>Kubes</surname><given-names>P</given-names></name><name><surname>Archer</surname><given-names>SL</given-names></name></person-group><article-title>Mitochondria in human neutrophils mediate killing of Staphylococcus aureus</article-title><source>Redox Biol</source><year>2022</year><volume>49</volume><pub-id pub-id-type="doi">10.1016/j.redox.2021.102225</pub-id></element-citation></ref><ref id="R71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goleva</surname><given-names>TN</given-names></name><name><surname>Lyamzaev</surname><given-names>KG</given-names></name><name><surname>Rogov</surname><given-names>AG</given-names></name><name><surname>Khailova</surname><given-names>LS</given-names></name><name><surname>Epremyan</surname><given-names>KK</given-names></name><name><surname>Shumakovich</surname><given-names>GP</given-names></name><name><surname>Domnina</surname><given-names>LV</given-names></name><name><surname>Ivanova</surname><given-names>OY</given-names></name><name><surname>Marmiy</surname><given-names>NV</given-names></name><name><surname>Zinevich</surname><given-names>TV</given-names></name><etal/></person-group><article-title>Mitochondria-targeted 1,4-naphthoquinone (SkQN) is a powerful prooxidant and cytotoxic agent</article-title><source>Biochim Biophys Acta-Bioenerg</source><year>2020</year><volume>1861</volume><elocation-id>148210</elocation-id><pub-id pub-id-type="doi">10.1016/j.bbabio.2020.148210</pub-id></element-citation></ref><ref id="R72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teixeira</surname><given-names>J</given-names></name><name><surname>Amorim</surname><given-names>R</given-names></name><name><surname>Santos</surname><given-names>K</given-names></name><name><surname>Soares</surname><given-names>P</given-names></name><name><surname>Datta</surname><given-names>S</given-names></name><name><surname>Cortopassi</surname><given-names>GA</given-names></name><name><surname>Serafim</surname><given-names>TL</given-names></name><name><surname>Sardão</surname><given-names>VA</given-names></name><name><surname>Garrido</surname><given-names>J</given-names></name><name><surname>Borges</surname><given-names>F</given-names></name><etal/></person-group><article-title>Disruption of mitochondrial function as mechanism for anti-cancer activity of a novel mitochondriotropic menadione derivative</article-title><source>Toxicology</source><year>2018</year><volume>393</volume><fpage>123</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.1016/j.tox.2017.11.014</pub-id></element-citation></ref><ref id="R73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mani</surname><given-names>S</given-names></name><name><surname>Wierzba</surname><given-names>T</given-names></name><name><surname>Walker</surname><given-names>RI</given-names></name></person-group><article-title>Status of vaccine research anddevelopment for Shigella</article-title><source>Vaccine</source><year>2016</year><volume>34</volume><fpage>2887</fpage><lpage>2894</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2016.02.075</pub-id></element-citation></ref><ref id="R74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>D</given-names></name><name><surname>Atsmon</surname><given-names>J</given-names></name><name><surname>Artaud</surname><given-names>C</given-names></name><name><surname>Meron-Sudai</surname><given-names>S</given-names></name><name><surname>Gougeon</surname><given-names>ML</given-names></name><name><surname>Bialik</surname><given-names>A</given-names></name><name><surname>Goren</surname><given-names>S</given-names></name><name><surname>Asato</surname><given-names>V</given-names></name><name><surname>Ariel-Cohen</surname><given-names>O</given-names></name><name><surname>Reizis</surname><given-names>A</given-names></name><etal/></person-group><article-title>Safety and immunogenicity of a synthetic carbohydrate conjugate vaccine against Shigella flexneri 2a in healthy adult volunteers: a phase 1, dose-escalating, single-blind, randomised, placebo-controlled study</article-title><source>Lancet Infect Dis</source><year>2021</year><volume>21</volume><fpage>546</fpage><lpage>558</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(20)30488-6</pub-id></element-citation></ref><ref id="R75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacLennan</surname><given-names>CA</given-names></name><name><surname>Grow</surname><given-names>S</given-names></name><name><surname>Ma</surname><given-names>LF</given-names></name><name><surname>Steele</surname><given-names>AD</given-names></name></person-group><article-title>The Shigella vaccines pipeline</article-title><source>Vaccines</source><year>2022</year><volume>10</volume><pub-id pub-id-type="doi">10.3390/vaccines10091376</pub-id></element-citation></ref><ref id="R76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>C</given-names></name><name><surname>Flores</surname><given-names>MV</given-names></name><name><surname>Storm</surname><given-names>T</given-names></name><name><surname>Crosier</surname><given-names>K</given-names></name><name><surname>Crosier</surname><given-names>P</given-names></name></person-group><article-title>The zebrafish lysozyme C promoter drives myeloid-specific expression in transgenic fish</article-title><source>BMC Dev Biol</source><year>2007</year><volume>7</volume><pub-id pub-id-type="doi">10.1038/44593</pub-id></element-citation></ref><ref id="R77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renshaw</surname><given-names>SA</given-names></name><name><surname>Loynes</surname><given-names>CA</given-names></name><name><surname>Trushell</surname><given-names>DMI</given-names></name><name><surname>Elworthy</surname><given-names>S</given-names></name><name><surname>Ingham</surname><given-names>PW</given-names></name><name><surname>Whyte</surname><given-names>MKB</given-names></name></person-group><article-title>A transgenic zebrafish model of neutrophilic inflammation</article-title><source>Blood</source><year>2006</year><volume>108</volume><fpage>3976</fpage><lpage>3978</lpage><pub-id pub-id-type="doi">10.1182/blood-2006-05-024075</pub-id></element-citation></ref><ref id="R78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellett</surname><given-names>F</given-names></name><name><surname>Pase</surname><given-names>L</given-names></name><name><surname>Hayman</surname><given-names>JW</given-names></name><name><surname>Andrianopoulos</surname><given-names>A</given-names></name><name><surname>Lieschke</surname><given-names>GJ</given-names></name></person-group><article-title>mpeg1 promoter transgenes direct macrophage-lineage expression in zebrafish</article-title><source>Blood</source><year>2011</year><volume>117</volume><pub-id pub-id-type="doi">10.1182/blood-2010-10-314120</pub-id></element-citation></ref><ref id="R79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernandez</surname><given-names>RE</given-names></name><name><surname>Galitan</surname><given-names>L</given-names></name><name><surname>Cameron</surname><given-names>J</given-names></name><name><surname>Goodwin</surname><given-names>N</given-names></name><name><surname>Ramakrishnan</surname><given-names>L</given-names></name></person-group><article-title>Delay of initial feeding of zebrafish larvae until 8 days postfertilization has no impact on survival or growth through the juvenile stage</article-title><source>Zebrafish</source><year>2018</year><volume>15</volume><fpage>515</fpage><lpage>518</lpage><pub-id pub-id-type="doi">10.1089/zeb.2018.1579</pub-id></element-citation></ref><ref id="R80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>SW</given-names></name><name><surname>Novitsky</surname><given-names>TJ</given-names></name><name><surname>Quinby</surname><given-names>HL</given-names></name><name><surname>Valois</surname><given-names>FW</given-names></name></person-group><article-title>Determination of bacterial number and biomass in the marine environment</article-title><source>Appl Environ Microbiol</source><year>1977</year><volume>33</volume><fpage>940</fpage><lpage>946</lpage><pub-id pub-id-type="doi">10.1128/aem.33.4.940-946.1977</pub-id></element-citation></ref><ref id="R81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Datsenko</surname><given-names>KA</given-names></name><name><surname>Wanner</surname><given-names>BL</given-names></name></person-group><article-title>One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products</article-title><source>Proc Natl Acad Sci</source><year>2000</year><volume>97</volume><fpage>6640</fpage><lpage>6645</lpage><pub-id pub-id-type="doi">10.1073/pnas.120163297</pub-id></element-citation></ref><ref id="R82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cherepanov</surname><given-names>PP</given-names></name><name><surname>Wackernagel</surname><given-names>W</given-names></name></person-group><article-title>Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibioticresistance determinant</article-title><source>Gene</source><year>1995</year><volume>158</volume><fpage>9</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/0378-1119(95)00193-A</pub-id></element-citation></ref><ref id="R83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellett</surname><given-names>F</given-names></name><name><surname>Lieschke</surname><given-names>GJ</given-names></name></person-group><article-title>Computational quantification of fluorescent leukocyte numbers in zebrafish embryos</article-title><source>Methods Enzymol</source><year>2012</year><volume>506</volume><fpage>425</fpage><lpage>435</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-391856-7.00046-9</pub-id></element-citation></ref><ref id="R84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niethammer</surname><given-names>P</given-names></name><name><surname>Grabher</surname><given-names>C</given-names></name><name><surname>Look</surname><given-names>AT</given-names></name><name><surname>Mitchison</surname><given-names>TJ</given-names></name></person-group><article-title>A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish</article-title><source>Nature</source><year>2009</year><volume>459</volume><fpage>996</fpage><lpage>999</lpage><pub-id pub-id-type="doi">10.1038/nature08119</pub-id></element-citation></ref><ref id="R85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clift</surname><given-names>DE</given-names></name><name><surname>Thorn</surname><given-names>RJ</given-names></name><name><surname>Passarelli</surname><given-names>EA</given-names></name><name><surname>Kapoor</surname><given-names>M</given-names></name><name><surname>LoPiccolo</surname><given-names>MK</given-names></name><name><surname>Richendrfer</surname><given-names>HA</given-names></name><name><surname>Colwill</surname><given-names>RM</given-names></name><name><surname>Creton</surname><given-names>R</given-names></name></person-group><article-title>Effects of embryonic cyclosporine exposures on brain development and behavior</article-title><source>Behav. Brain Res</source><year>2015</year><volume>282</volume><fpage>117</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1016/j.bbr.2015.01.006</pub-id></element-citation></ref><ref id="R86"><label>86</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Rougeot</surname><given-names>J</given-names></name><name><surname>Zakrzewska</surname><given-names>A</given-names></name><name><surname>Kanwal</surname><given-names>Z</given-names></name><name><surname>Jansen</surname><given-names>HJ</given-names></name><name><surname>Spaink</surname><given-names>HP</given-names></name><name><surname>Meijer</surname><given-names>AH</given-names></name></person-group><chapter-title>RNA sequencing of FACS-sorted immune cell populations from zebrafish infection models to identify cell specific responses to intracellular pathogens</chapter-title><person-group person-group-type="editor"><name><surname>Vergunst</surname><given-names>AC</given-names></name><name><surname>O’Callaghan</surname><given-names>D</given-names></name></person-group><source>HostBacteria Interactions: Methods and Protocols</source><publisher-name>Springer</publisher-name><publisher-loc>New York</publisher-loc><year>2014</year><fpage>261</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-1261-2_15</pub-id></element-citation></ref><ref id="R87"><label>87</label><element-citation publication-type="web"><person-group person-group-type="author"><name><surname>Andrews</surname><given-names>S</given-names></name></person-group><source>FastQC: A quality control tool for high throughput sequence data</source><year>2010</year><comment>Avaliable online at: <ext-link ext-link-type="uri" xlink:href="https://www.bioinformatics.babraham.ac.uk/projects/fastqc/">https://www.bioinformatics.babraham.ac.uk/projects/fastqc/</ext-link></comment></element-citation></ref><ref id="R88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langmead</surname><given-names>B</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name></person-group><article-title>Fast gapped-read alignment with Bowtie 2</article-title><source>Nat Methods</source><year>2012</year><volume>9</volume><fpage>357</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1923</pub-id></element-citation></ref><ref id="R89"><label>89</label><element-citation publication-type="web"><collab>Broad Institute</collab><source>Picard toolkit</source><year>2019</year><comment>Available online at: <ext-link ext-link-type="uri" xlink:href="http://broadinstitute.github.io/picard/">http://broadinstitute.github.io/picard/</ext-link></comment></element-citation></ref><ref id="R90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Qin</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>XS</given-names></name></person-group><article-title>Identifying ChIP-seq enrichment using MACS</article-title><source>Nat Protoc</source><year>2012</year><volume>7</volume><fpage>1728</fpage><lpage>1740</lpage><pub-id pub-id-type="doi">10.1038/nprot.2012.101</pub-id></element-citation></ref><ref id="R91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Brown</surname><given-names>JB</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Bickel</surname><given-names>PJ</given-names></name></person-group><article-title>Measuring reproducibility of high-throughput experiments</article-title><source>Ann Appl Stat</source><year>2011</year><volume>5</volume><fpage>1752</fpage><lpage>1779</lpage><pub-id pub-id-type="doi">10.1214/11-AOAS466</pub-id></element-citation></ref><ref id="R92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>LG</given-names></name><name><surname>He</surname><given-names>QY</given-names></name></person-group><article-title>ChIP seeker: An R/Bioconductor package for ChIP peak annotation, comparison and visualization</article-title><source>Bioinformatics</source><year>2015</year><volume>31</volume><fpage>2382</fpage><lpage>2383</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btv145</pub-id></element-citation></ref><ref id="R93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>JT</given-names></name><name><surname>Thorvaldsdóttir</surname><given-names>H</given-names></name><name><surname>Winckler</surname><given-names>W</given-names></name><name><surname>Guttman</surname><given-names>M</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Getz</surname><given-names>G</given-names></name><name><surname>Mesirov</surname><given-names>JP</given-names></name></person-group><article-title>Integrative genomics viewer</article-title><source>Nat Biotechnol</source><year>2011</year><volume>29</volume><fpage>24</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1038/nbt.1754</pub-id></element-citation></ref><ref id="R94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otasek</surname><given-names>D</given-names></name><name><surname>Morris</surname><given-names>JH</given-names></name><name><surname>Bouças</surname><given-names>J</given-names></name><name><surname>Pico</surname><given-names>AR</given-names></name><name><surname>Demchak</surname><given-names>B</given-names></name></person-group><article-title>Cytoscape Automation: Empowering workflow-based network analysis</article-title><source>Genome Biol</source><year>2019</year><volume>20</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1186/s13059-019-1758-4</pub-id></element-citation></ref><ref id="R95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bindea</surname><given-names>G</given-names></name><name><surname>Mlecnik</surname><given-names>B</given-names></name><name><surname>Hackl</surname><given-names>H</given-names></name><name><surname>Charoentong</surname><given-names>P</given-names></name><name><surname>Tosolini</surname><given-names>M</given-names></name><name><surname>Kirilovsky</surname><given-names>A</given-names></name><name><surname>Fridman</surname><given-names>WH</given-names></name><name><surname>Pagès</surname><given-names>F</given-names></name><name><surname>Trajanoski</surname><given-names>Z</given-names></name><name><surname>Galon</surname><given-names>J</given-names></name></person-group><article-title>ClueGO: A Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks</article-title><source>Bioinformatics</source><year>2009</year><volume>25</volume><fpage>1091</fpage><lpage>1093</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp101</pub-id></element-citation></ref><ref id="R96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mostowy</surname><given-names>S</given-names></name><name><surname>Bonazzi</surname><given-names>M</given-names></name><name><surname>Hamon</surname><given-names>MA</given-names></name><name><surname>Tham</surname><given-names>TN</given-names></name><name><surname>Mallet</surname><given-names>A</given-names></name><name><surname>Lelek</surname><given-names>M</given-names></name><name><surname>Gouin</surname><given-names>E</given-names></name><name><surname>Demangel</surname><given-names>C</given-names></name><name><surname>Brosch</surname><given-names>R</given-names></name><name><surname>Zimmer</surname><given-names>C</given-names></name><etal/></person-group><article-title>Entrapment of intracytosolic bacteria by septin cage-like structures</article-title><source>Cell Host Microbe</source><year>2010</year><volume>8</volume><fpage>433</fpage><lpage>444</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2010.10.009</pub-id></element-citation></ref><ref id="R97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wandel</surname><given-names>MP</given-names></name><name><surname>Pathe</surname><given-names>C</given-names></name><name><surname>Werner</surname><given-names>EI</given-names></name><name><surname>Ellison</surname><given-names>CJ</given-names></name><name><surname>Boyle</surname><given-names>KB</given-names></name><name><surname>von der Malsburg</surname><given-names>A</given-names></name><name><surname>Rohde</surname><given-names>J</given-names></name><name><surname>Randow</surname><given-names>F</given-names></name></person-group><article-title>GBPs inhibit motility of Shigella flexneri but are targeted for degradation by the bacterial ubiquitin ligase IpaH9.8</article-title><source>Cell Host Microbe</source><year>2017</year><volume>22</volume><fpage>507</fpage><lpage>518</lpage><elocation-id>e5</elocation-id><pub-id pub-id-type="doi">10.1016/j.chom.2017.09.007</pub-id></element-citation></ref><ref id="R98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCarthy</surname><given-names>RR</given-names></name><name><surname>Mazon-Moya</surname><given-names>MJ</given-names></name><name><surname>Moscoso</surname><given-names>JA</given-names></name><name><surname>Hao</surname><given-names>Y</given-names></name><name><surname>Lam</surname><given-names>JS</given-names></name><name><surname>Bordi</surname><given-names>C</given-names></name><name><surname>Mostowy</surname><given-names>S</given-names></name><name><surname>Filloux</surname><given-names>A</given-names></name></person-group><article-title>Cyclic-di-GMP regulates lipopolysaccharide modification and contributes to Pseudomonas aeruginosa immune evasion</article-title><source>Nat Microbiol</source><year>2017</year><volume>2</volume><elocation-id>17027</elocation-id><pub-id pub-id-type="doi">10.1038/nmicrobiol.2017.27</pub-id></element-citation></ref><ref id="R99"><label>99</label><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Ulhuq</surname><given-names>FR</given-names></name><name><surname>Gomes</surname><given-names>MC</given-names></name><name><surname>Duggan</surname><given-names>GM</given-names></name><name><surname>Guo</surname><given-names>M</given-names></name><name><surname>Mendonca</surname><given-names>C</given-names></name><name><surname>Buchanan</surname><given-names>G</given-names></name><name><surname>Chalmers</surname><given-names>JD</given-names></name><name><surname>Cao</surname><given-names>Z</given-names></name><name><surname>Kneuper</surname><given-names>H</given-names></name><name><surname>Murdoch</surname><given-names>S</given-names></name><etal/></person-group><source>A membranedepolarizing toxin substrate of the Staphylococcus aureus type VII secretion system mediates intraspecies competition</source><conf-name>PNAS</conf-name><year>2020</year><comment>/-/DCSupplemental</comment><pub-id pub-id-type="doi">10.1073/pnas.2006110117</pub-id></element-citation></ref><ref id="R100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alter</surname><given-names>A</given-names></name><name><surname>De Léséleuc</surname><given-names>L</given-names></name><name><surname>Van Thuc</surname><given-names>N</given-names></name><name><surname>Thai</surname><given-names>VH</given-names></name><name><surname>Huong</surname><given-names>NT</given-names></name><name><surname>Ba</surname><given-names>NN</given-names></name><name><surname>Cardoso</surname><given-names>CC</given-names></name><name><surname>Grant</surname><given-names>AV</given-names></name><name><surname>Abel</surname><given-names>L</given-names></name><name><surname>Moraes</surname><given-names>MO</given-names></name><etal/></person-group><article-title>Genetic and functional analysis of common MRC1 exon 7 polymorphisms in leprosy susceptibility</article-title><source>Hum Genet</source><year>2010</year><volume>127</volume><fpage>337</fpage><lpage>348</lpage><pub-id pub-id-type="doi">10.1007/s00439-009-0775-x</pub-id></element-citation></ref><ref id="R101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herbst</surname><given-names>S</given-names></name><name><surname>Shah</surname><given-names>A</given-names></name><name><surname>Mazon Moya</surname><given-names>M</given-names></name><name><surname>Marzola</surname><given-names>V</given-names></name><name><surname>Jensen</surname><given-names>B</given-names></name><name><surname>Reed</surname><given-names>A</given-names></name><name><surname>Birrell</surname><given-names>MA</given-names></name><name><surname>Saijo</surname><given-names>S</given-names></name><name><surname>Mostowy</surname><given-names>S</given-names></name><name><surname>Shaunak</surname><given-names>S</given-names></name><etal/></person-group><article-title>Phagocytosis-dependent activation of a TLR9-BTK-calcineurin-NFAT pathway co-ordinates innate immunity to Aspergillus fumigatus</article-title><source>EMBO Mol Med</source><year>2015</year><volume>7</volume><fpage>240</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.15252/emmm.201404556</pub-id></element-citation></ref><ref id="R102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stockhammer</surname><given-names>OW</given-names></name><name><surname>Zakrzewska</surname><given-names>A</given-names></name><name><surname>Hegedûs</surname><given-names>Z</given-names></name><name><surname>Spaink</surname><given-names>HP</given-names></name><name><surname>Meijer</surname><given-names>AH</given-names></name></person-group><article-title>Transcriptome profiling and functional analyses of the zebrafish embryonic innate immune response to Salmonella infection</article-title><source>J Immunol</source><year>2009</year><volume>182</volume><fpage>5641</fpage><lpage>5653</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0900082</pub-id></element-citation></ref><ref id="R103"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torraca</surname><given-names>V</given-names></name><name><surname>Otto</surname><given-names>NA</given-names></name><name><surname>Tavakoli-Tameh</surname><given-names>A</given-names></name><name><surname>Meijer</surname><given-names>AH</given-names></name></person-group><article-title>The inflammatory chemokine Cxcl18b exerts neutrophil-specific chemotaxis via the promiscuous chemokine receptor Cxcr2 in zebrafish</article-title><source>Dev Comp Immunol</source><year>2017</year><volume>67</volume><fpage>57</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/j.dci.2016.10.014</pub-id></element-citation></ref><ref id="R104"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varela</surname><given-names>M</given-names></name><name><surname>Dios</surname><given-names>S</given-names></name><name><surname>Novoa</surname><given-names>B</given-names></name><name><surname>Figueras</surname><given-names>A</given-names></name></person-group><article-title>Characterisation, expression and ontogeny of interleukin-6 and its receptors in zebrafish (Danio rerio)</article-title><source>Dev Comp Immunol</source><year>2012</year><volume>37</volume><fpage>97</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1016/j.dci.2011.11.004</pub-id></element-citation></ref><ref id="R105"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boucontet</surname><given-names>L</given-names></name><name><surname>Passoni</surname><given-names>G</given-names></name><name><surname>Thiry</surname><given-names>V</given-names></name><name><surname>Maggi</surname><given-names>L</given-names></name><name><surname>Herbomel</surname><given-names>P</given-names></name><name><surname>Levraud</surname><given-names>JP</given-names></name><name><surname>Colucci-Guyon</surname><given-names>E</given-names></name></person-group><article-title>A model of superinfection of virus-infected zebrafish larvae: Increased susceptibility to bacteria associated with neutrophil death</article-title><source>Front Immunol</source><year>2018</year><volume>9</volume><elocation-id>1084</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.01084</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><title>Zebrafish exposure to non-lethal <italic>Shigella</italic> dose induces generation of more resilient neutrophils.</title><p><bold>A</bold> Experimental outline of 2 dpf zebrafish larvae injected in the HBV with PBS or a non-lethal dose of <italic>Shigella</italic>.</p><p><bold>B</bold> Representative images of Tg(<italic>lyz</italic>::dsRed) larvae with red neutrophils at 48 hp1i with a non-lethal dose of <italic>S. flexneri</italic> M90T. Scale bar: 500 μm.</p><p><bold>C</bold> Quantification of neutrophils (Tg(<italic>lyz</italic>::dsRed)) at 0, 24 and 48 hp1i injected with PBS (naïve- black full circles) and a non-lethal dose of <italic>S. flexneri</italic> M90T (green full circles, 2x10<sup>3</sup> ± 1.4x10<sup>3</sup> CFUs). Data pooled from 3 experiments with n=10 larvae per time point per condition per experiment (mean ± SD, *p &lt; 0.05, ***p &lt; 0.001, 2-way ANOVA with Sidak’s multiple comparisons test).</p><p><bold>D</bold> Quantification of macrophages (Tg(<italic>mpeg</italic>::mCherry)) at 0, 24 and 48 hp1i injected with PBS (naïve- black full circles) and a non-lethal dose of <italic>S. flexneri</italic> M90T (green full circles, 1.8x10<sup>3</sup> ± 8.6x10<sup>2</sup> CFUs). Data pooled from 3 experiments with n&gt;11 larvae per time point per condition per experiment (mean ± SD, ****p &lt; 0.0001, 2-way ANOVA with Sidak’s multiple comparisons test).</p><p><bold>E</bold> Fold change in the expression of <italic>cxcl8a</italic>, <italic>cxcl18b</italic>, <italic>il1b</italic> and <italic>il10</italic> in larvae injected with non-lethal dose of <italic>S. flexneri</italic> M90T (green full bars, 1.3x10<sup>3</sup> ± 5.5x10<sup>2</sup> CFUs) as compared to PBS control (naïve- black full bars). Data pooled from 3 experiments with n&gt;5 larvae per time point per condition per experiment (mean ± SEM, **p &lt; 0.01, ***p &lt; 0.001, ****p &lt; 0.0001, 2-way ANOVA with Sidak’s multiple comparisons test).</p><p><bold>F</bold> Experimental outline of 2 dpf zebrafish larvae injected in the HBV with PBS or a non-lethal dose of <italic>Shigella</italic> followed by a lethal dose injection of <italic>S. flexneri</italic> M90T at 4dpf in the HBV.</p><p><bold>G</bold> Representative images of naïve and <italic>Shigella</italic>-primed larvae (Tg(<italic>lyz</italic>::dsRed)) with red neutrophils infected with a lethal dose of <italic>S. flexneri</italic> M90T at 1 and 12 hp2i. Scale bar: 50 μm.</p><p><bold>H</bold> Quantification of recruited neutrophils (Tg(<italic>lyz</italic>::dsRed)) to the HBV in naïve (black full circles) and <italic>Shigella</italic>-primed (green full circles) larvae at 1, 3, 6 and 12 h following injection of a lethal dose of <italic>S. flexneri</italic> M90T (PBS - 2.6x10<sup>4</sup> ± 9x10<sup>3</sup> CFUs, <italic>Shigella</italic> - 2.7x10<sup>4</sup> ± 1x10<sup>4</sup> CFUs). Data pooled from 3 experiments with n=5 larvae per time point per condition per experiment (mean ± SD, 2-way ANOVA with Sidak’s multiple comparisons test).</p><p><bold>I</bold> Log10-transformed CFU counts of naïve and <italic>Shigella</italic>-primed larvae injected with a lethal dose of <italic>S. flexneri</italic> M90T (PBS - 2.7x10<sup>4</sup> ± 4.5x10<sup>3</sup> CFUs, <italic>Shigella</italic> - 2.5x10<sup>4</sup> ± 1x10<sup>4</sup> CFUs). Data pooled from 3 independent experiments using n=3 larvae per condition per experiment (mean ± SD, ****p &lt; 0.0001, 2-way ANOVA with Sidak’s multiple comparisons test).</p><p><bold>J</bold> Fold change in the expression of <italic>cxcl8a</italic>, <italic>cxcl18b</italic>, <italic>il1b</italic> and <italic>il10</italic> following lethal dose injection of <italic>S. flexneri</italic> M90T in naïve (black full bars, 2.5x10<sup>4</sup> ± 1x10<sup>4</sup> CFUs) and <italic>Shigella</italic>-primed (green full bars, 2.7x10<sup>4</sup> ± 4.5x10<sup>3</sup> CFUs) as compared to PBS injected controls (grey bars). Data pooled from 3 experiments with n&gt;5 larvae per time point per condition per experiment (mean ± SEM, **p &lt; 0.01, ****p &lt; 0.0001, 2-way ANOVA with Sidak’s multiple comparisons test).</p></caption><graphic xlink:href="EMS156690-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title><italic>Shigella</italic> induced protection is non-specific and long lasting.</title><p><bold>A</bold> Experimental outline of 2 dpf zebrafish larvae injected in the HBV with PBS or a non-lethal dose of <italic>Shigella</italic> followed by a lethal dose injection of <italic>P</italic>. aeruginosa or <italic>S. aureus</italic> at 4 dpf in the HBV.</p><p><bold>B</bold> Survival curves from naïve (black full circles) and <italic>Shigella</italic>-primed (green full circles, 2.2x10<sup>3</sup> ± 3.8x10<sup>2</sup> CFUs) larvae infected with a lethal dose of <italic>P. aeruginosa</italic> (PBS – 2.6x10<sup>3</sup> ± 7.4x10<sup>2</sup> CFUs, <italic>Shigella</italic> – 2.3x10<sup>3</sup> ± 5.5x10<sup>2</sup> CFUs). Data pooled from 3 independent experiments using n=20 larvae per condition per experiment (****p &lt; 0.0001, Log-rank (Mantel-Cox) test).</p><p><bold>C</bold> Survival curves from naïve (black full circles) and <italic>Shigella-primed</italic> (green full circles, 1.8x10<sup>3</sup> ± 7x10<sup>2</sup> CFUs) larvae infected with a lethal dose of <italic>S. aureus</italic> (PBS – 1.7x10<sup>4</sup> ± 4.5x10<sup>3</sup> CFUs, <italic>Shigella</italic> – 2.6x10<sup>4</sup> ± 1x10<sup>4</sup> CFUs). Data pooled from 3 independent experiments using n&gt; 20 larvae per condition per experiment (****p &lt; 0.0001, Log-rank (Mantel-Cox) test).</p><p><bold>D</bold> Experimental outline of 2 dpf zebrafish larvae injected in the HBV with PBS or a non-lethal dose of <italic>Shigella</italic> followed by a lethal dose injection of <italic>S. flexneri</italic> M90T at 7 dpf (or 5 dpi) in the HBV.</p><p><bold>E</bold> Representative images of naïve and <italic>Shigella</italic>-primed Tg(<italic>lyz</italic>::dsRed) larvae with red neutrophils at 5 dp1i.</p><p><bold>F</bold> Quantification of total fluorescence in Tg(<italic>lyz</italic>::dsRed) naïve (black full circles) and <italic>Shigella- primed</italic> (green full circles, 1.7x10<sup>3</sup> ± 5.7x10<sup>2</sup> CFUs) larvae at 5dp1i. Data pooled from 2 experiments with n=10 larvae per condition per experiment (mean ± SD, *p &lt; 0.05, unpaired Student’s <italic>t</italic>-test).</p><p><bold>G</bold> Survival curves from naïve (black full circles) and <italic>Shigella-primed</italic> (green full circles) larvae infected with a lethal dose of <italic>S. flexneri</italic> M90T at 5 dp1i. Data pooled from 3 independent experiments using n&gt;16 larvae per condition per experiment (*p &lt; 0.05, Logrank (Mantel-Cox) test).</p><p><bold>H</bold> Log<sub>10</sub>-transformed CFU counts of naïve and <italic>Shigella</italic>-primed (in green section: 1.7x10<sup>3</sup> ± 5.7x10<sup>2</sup> CFUs) larvae injected with a lethal dose of <italic>S. flexneri</italic> M90T (in red section: PBS - 2.7x10<sup>4</sup> ± 4.5x10<sup>3</sup> CFUs, <italic>Shigella</italic> - 2.5x10<sup>4</sup> ± 1x10<sup>4</sup> CFUs). Data pooled from 3 independent experiments using n&gt;2 larvae per condition per experiment (mean ± SD, 2-way ANOVA with Sidak’s multiple comparisons test).</p></caption><graphic xlink:href="EMS156690-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><title>BCG and β-glucan induce protection in zebrafish embryos.</title><p><bold>A</bold> Experimental outline of 2 dpf zebrafish larvae injected in the HBV with PBS or a non-lethal dose of BCG followed by a lethal dose injection of <italic>S. flexneri</italic> M90T at 4 dpf in the HBV. During priming (48 hp1i) larvae were kept at 33°C and during reinfection they were kept at 28.5°C.</p><p><bold>B</bold> Survival curves from naïve (black full circles) and BCG-primed (purple full circles) larvae infected with a lethal dose of <italic>S. flexneri</italic> M90T. Data pooled from 3 independent experiments using n&gt;17 larvae per condition per experiment (**p &lt; 0.01, Log-rank (Mantel-Cox) test).</p><p><bold>C</bold> Log<sub>10</sub>-transformed CFU counts of naïve and BCG-primed (in purple section: 4.7x10<sup>1</sup> ± 3.2x10<sup>1</sup> CFUs) larvae injected with a lethal dose of <italic>S. flexneri</italic> M90T (in red section: PBS – 3.5x10<sup>4</sup> ± 6.8x10<sup>3</sup> CFUs, BCG – 3.9x10<sup>4</sup> ± 7.5x10<sup>3</sup> CFUs). Data pooled from 3 independent experiments using n=3 larvae per condition per experiment (mean ± SD, 2-way ANOVA with Sidak’s multiple comparisons test).</p><p><bold>D</bold> Fold change in the expression of <italic>cxcl8a, cxcl18b, il1b, il6, tnfa, gcsfa</italic> and <italic>il10</italic> following non-lethal dose injection of BCG (purple bars, 4.7x10<sup>1</sup> ± 3.2x10<sup>1</sup> CFUs) as compared to PBS injected controls (grey bars). Data pooled from 3 experiments with n=10 larvae per time point per condition per experiment (mean ± SEM, *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001, ****p &lt; 0.0001, unpaired Student’s <italic>t</italic>-test).</p><p><bold>E</bold> Representative images of naïve and BCG-primed Tg(<italic>lyz</italic>::dsRed) larvae with red neutrophils at 48 hp1i. Scale bar: 500 μm.</p><p><bold>F</bold> Quantification of neutrophils (Tg(<italic>lyz</italic>::dsRed)) at 0, 24 and 48 hp1i injected with PBS (naïve- black full circles) and a non-lethal dose of BCG (purple full circles, 5.6x10<sup>1</sup> ± 4.3x10<sup>1</sup> CFUs). Data pooled from 3 experiments with n&gt;13 larvae per time point per condition per experiment (mean ± SD, 2-way ANOVA with Sidak’s multiple comparisons test).</p><p><bold>G</bold> Quantification of macrophages (Tg(<italic>mpeg</italic>::mCherry)) at 0, 24 and 48 hp1i injected with PBS (naïve- black full circles) and a non-lethal dose of BCG (purple full circles, 6.3x10<sup>1</sup> ± 3.7x10<sup>1</sup> CFUs). Data pooled from 3 experiments with n&gt;12 larvae per time point per condition per experiment (mean ± SD, 2-way ANOVA with Sidak’s multiple comparisons test).</p><p><bold>H</bold> Experimental outline of 2 dpf zebrafish larvae injected in the HBV with PBS or non-lethal dose of β-glucan followed by a lethal dose injection of <italic>S. flexneri</italic> M90T at 4 dpf in the HBV.</p><p><bold>I</bold> Survival curves from naïve (black full circles) and β-glucan-primed (blue full circles, 20 ng) larvae infected with a lethal dose of <italic>S. flexneri</italic> M90T. Data pooled from 3 independent experiments using n&gt;18 larvae per condition per experiment (**p &lt; 0.01, Log-rank (MantelCox) test).</p><p><bold>J</bold> Log<sub>10</sub>-transformed CFU counts of naïve and β-glucan-primed larvae injected with a lethal dose of <italic>S. flexneri</italic> M90T (PBS – 2.5x10<sup>4</sup> ± 7.3x10<sup>3</sup> CFUs, β-glucan – 2.6x10<sup>4</sup> ± 5.9x10<sup>3</sup> CFUs). Data pooled from 3 independent experiments using n=3 larvae per condition per experiment (mean ± SD, **p &lt; 0.01,2-way ANOVA with Sidak’s multiple comparisons test).</p><p><bold>K</bold> Fold change in the expression of <italic>cxcl8a, cxcl18b, il1b, il6, tnfa, gcsfa</italic> and <italic>il10</italic> following non-lethal dose injection of β-glucan (blue bars, 20 ng) as compared to PBS injected controls (black bars). Data pooled from 3 experiments with n=10 larvae per time point per condition per experiment (mean ± SEM, *p &lt; 0.05, **p &lt; 0.01, unpaired Student’s <italic>t</italic>-test).</p><p><bold>L</bold> Representative images of naïve and β-glucan-primed Tg(<italic>lyz</italic>::dsRed) larvae with red neutrophils at 48 hp1i. Scale bar: 500 μm.</p><p><bold>M</bold> Quantification of neutrophils (Tg(<italic>lyz</italic>::dsRed)) at 0, 24 and 48 hp1i injected with PBS (naïve- black full circles) and a non-lethal dose of β-glucan (blue full circles, 20 ng). Data pooled from 3 experiments with n&gt;8 larvae per time point per condition per experiment (mean ± SD, **p &lt; 0.01,2-way ANOVA with Sidak’s multiple comparisons test).</p><p><bold>N</bold> Quantification of macrophages (Tg(<italic>mpeg</italic>::mCherry)) at 0, 24 and 48 hp1i injected with PBS (naïve- black full circles) and a non-lethal dose of β-glucan (blue full circles, 20 ng). Data pooled from 3 experiments with n&gt;11 larvae per time point per condition per experiment (mean ± SD, ****p &lt; 0.0001, 2-way ANOVA with Sidak’s multiple comparisons test).</p></caption><graphic xlink:href="EMS156690-f003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><title><italic>Shigella</italic> stimulates inflammatory pathways to induce training.</title><p><bold>A</bold> Experimental outline of exposure of 2 dpf zebrafish larvae to nigericin and glucose for 24, 48 or 96h followed by a lethal dose injection of <italic>S. flexneri</italic> M90T at 4 dpf in the HBV.</p><p><bold>B</bold> Survival curves from E2 (embryo media control, black full circles) and nigericin (blue full circles, 0.1 μM) treated larvae infected with a lethal dose of <italic>S. flexneri</italic> M90T (PBS – 2.7x10<sup>4</sup> ± 8.5x10<sup>3</sup> CFUs, nigericin – 2.6x10<sup>4</sup> ± 4.1x10<sup>3</sup> CFUs). Data pooled from 3 independent experiments using n&gt;14 larvae per condition per experiment (Log-rank (Mantel-Cox) test).</p><p><bold>C</bold> Survival curves from E2 (embryo media control, black full circles) and glucose (blue full circles, 1%) treated larvae infected with a lethal dose of <italic>S. flexneri</italic> M90T (PBS – 2.7x10<sup>4</sup> ± 8.5x10<sup>3</sup> CFUs, glucose – 2.7x10<sup>4</sup> ± 1x10<sup>4</sup> CFUs). Data pooled from 3 independent experiments using n&gt;14 larvae per condition per experiment (Log-rank (Mantel-Cox) test).</p><p><bold>D</bold> Experimental outline of 2 dpf zebrafish larvae injected in the HBV with PBS, non-lethal dose of live or killed <italic>Shigella, Shigella</italic> mutants or LPS followed by a lethal dose injection of <italic>S. flexneri</italic> M90T at 4 dpf in the HBV.</p><p><bold>E</bold> Survival curves from naïve (black full circles), live <italic>Shigella</italic>-primed (green full circles, 1.3x10<sup>3</sup> ± 6.6x10<sup>2</sup> CFUs), heat-killed (HK) <italic>Shigella-primed</italic> (dark green/white squares) and PFA-killed <italic>Shigella-primed</italic> (dark green/white triangles) larvae infected with a lethal dose of <italic>S. flexneri</italic> M90T (PBS – 2.7x10<sup>4</sup> ± 6.1x10<sup>3</sup> CFUs, <italic>Shigella</italic> – 2.7x10<sup>4</sup> ± 1x10<sup>4</sup> CFUs, <italic>Shigella</italic> HK – 3.2x10<sup>4</sup> ± 3.3x10<sup>4</sup> CFUs, <italic>Shigella</italic> PFA – 3.2x10<sup>4</sup> ± 1.7x10<sup>4</sup> CFUs). Data pooled from 3 independent experiments using n&gt;11 larvae per condition per experiment. (*p &lt; 0.05, **p &lt; 0.01, ****p &lt; 0.0001, Log-rank (Mantel-Cox) test).</p><p><bold>F</bold> Survival curves from naïve (black full circles), <italic>Shigella</italic>-primed (green full circles, 1.6x10<sup>3</sup> ± 6.5x10<sup>2</sup> CFUs) and LPS-primed (moss green full circles, 0.125 ng) larvae infected with a lethal dose of <italic>S. flexneri</italic> M90T (PBS – 1.9x10<sup>4</sup> ± 6.3x10<sup>3</sup> CFUs, <italic>Shigella</italic> – 2.8x10<sup>4</sup> ± 4.7x10<sup>3</sup> CFUs, LPS – 1.9x10<sup>4</sup> ± 9.1x10<sup>3</sup> CFUs). Data pooled from 3 independent experiments using n&gt;18 larvae per condition per experiment. (***p &lt; 0.001, ****p &lt; 0.0001, Log-rank (MantelCox) test).</p><p><bold>G</bold> Survival curves from naïve (black full circles), <italic>Shigella-primed</italic> (green full circles, 1.6x10<sup>3</sup> ± 6.5x10<sup>2</sup> CFUs) and Shigella Δ<italic>rfaC</italic>-primed (moss green full circles, 8.5x10<sup>2</sup> ± 7.5x10<sup>2</sup> CFUs) larvae infected with a lethal dose of <italic>S. flexneri</italic> M90T (PBS – 1.9x10<sup>4</sup> ± 6.3x10<sup>3</sup> CFUs, <italic>Shigella</italic> – 2.8x10<sup>4</sup> ± 4.7x10<sup>3</sup> CFUs, <italic>ΔrfaC</italic> – 2.4x10<sup>4</sup> ± 8.4x10<sup>3</sup> CFUs). Data pooled from 3 independent experiments using n&gt;10 larvae per condition per experiment (****p &lt; 0.0001, Log-rank (Mantel-Cox) test).</p><p><bold>H</bold> Survival curves from naïve (black full circles), <italic>Shigella-primed</italic> (green full circles, 7.9x10<sup>2</sup> ± 5.5x10<sup>2</sup> CFUs) and Shigella Δ<italic>mxiE</italic>-primed (moss green full circles, 8.8x10<sup>2</sup> ± 5.8x10<sup>2</sup> CFUs) larvae infected with a lethal dose of <italic>S. flexneri</italic> M90T (PBS – 1.9x10<sup>4</sup> ± 7.5x10<sup>3</sup> CFUs, <italic>Shigella</italic> – 2.5x10<sup>4</sup> ± 4.6x10<sup>3</sup> CFUs, <italic>ΔmxiE</italic> – 2.2x10<sup>4</sup> ± 7.6x10<sup>3</sup> CFUs). Data pooled from 3 independent experiments using n&gt;10 larvae per condition per experiment. (****p &lt; 0.0001, Log-rank (Mantel-Cox) test).</p></caption><graphic xlink:href="EMS156690-f004"/></fig><fig id="F5" position="float"><label>Figure 5</label><caption><title>Exposure to <italic>Shigella</italic> induces epigenetic reprogramming of neutrophils</title><p><bold>A</bold> Experimental outline of FACS-sorting neutrophils from naïve and <italic>Shigella-primed</italic> larvae for ChIP-seq on H3k4me3 modification.</p><p><bold>B</bold> Venn diagram showing number of common and unique genes marked by H3K4me3 peaks in their promoter regions (±3kb from TSS) of PBS and <italic>Shigella</italic> ΔT3SS primed larvae.</p><p><bold>C</bold> Enriched KEGG-pathways (<italic>p</italic>-value &lt; 0.01) associated with the 2052 unique <italic>Shigella</italic> ΔT3SS priming genes marked by a H3K4me3 peak in their promoter regions (±3kb from TSS).</p><p><bold>D</bold> Venn diagram showing number of common and unique genes marked by H3K4me3 peaks in their promoter regions (±3kb from TSS) of PBS and <italic>Shigella</italic> WT primed larvae.</p><p><bold>E</bold> Enriched KEGG-pathways (<italic>p</italic>-value &lt; 0.01) associated with the 1612 unique <italic>Shigella</italic> WT priming genes marked by a H3K4me3 peak in their promoter regions (±3kb from TSS).</p></caption><graphic xlink:href="EMS156690-f005"/></fig><fig id="F6" position="float"><label>Figure 6</label><caption><title>Trained neutrophils produce more ROS.</title><p><bold>A</bold> Increased calcium transportation into the mitochondrial inner membrane via the mitochondrial permeability transition pore (VDAC and MCU) increases mtROS produced by TCA and oxidative phosphorylation.</p><p><bold>B</bold> Normalised fluorescence of MitoTracker Red CM-H<sub>2</sub>XRos (red) dye in neutrophils from naïve (black outlines) and <italic>Shigella-primed</italic> (green outlines, 1.2x10<sup>3</sup> ± 5.3x10<sup>2</sup> CFUs) larvae (Tg(<italic>mpx</italic>::GFP)) unstimulated (grey fills) or infected with a lethal dose of <italic>S. flexneri</italic> M90T (PBS – black fill, 2.6x10<sup>4</sup> ± 9.3x10<sup>3</sup> CFUs, <italic>Shigella</italic> – green fill, 3x10<sup>4</sup> ± 6.6x10<sup>3</sup> CFUs) at 6 hp2i. Data pooled from 3 experiments with n&gt;10 larvae per condition per experiment (mean ± SD, ****p &lt; 0.0001,2-way ANOVA with Sidak’s multiple comparisons test).</p><p><bold>C</bold> Normalised fluorescence of CellROX Deep Red dye in neutrophils from naïve (black outlines) and <italic>Shigella-primed</italic> (green outlines, 1.4x10<sup>3</sup> ± 6.7x10<sup>2</sup> CFUs) larvae (Tg(<italic>mpx</italic>::GFP)) unstimulated (grey fills) or infected with a lethal dose of <italic>S. flexneri</italic> M90T (PBS – black fill, 2.6x10<sup>4</sup> ± 1x10<sup>4</sup> CFUs, <italic>Shigella</italic> – green fill, 2.6x10<sup>4</sup> ± 1x10<sup>4</sup> CFUs) at 6 hp2i. Data pooled from 3 experiments with n&gt;10 larvae per condition per experiment (mean ± SD, ****p &lt; 0.0001,2-way ANOVA with Sidak’s multiple comparisons test).</p></caption><graphic xlink:href="EMS156690-f006"/></fig><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1</label><caption><title>Comparison of training phenotypes between <italic>Shigella</italic>-, BCG- and β-glucan-primed zebrafish larvae.</title></caption><table frame="box" rules="all"><thead><tr><th align="center" valign="middle" colspan="2"/><th align="center" valign="middle"><italic>Shigella</italic></th><th align="center" valign="middle">BCG</th><th align="center" valign="middle">β-glucan</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="5"><bold>Training</bold></td><td align="left" valign="middle">Bacterial clearance</td><td align="center" valign="middle">YES</td><td align="center" valign="middle">NO</td><td align="center" valign="middle">--</td></tr><tr><td align="left" valign="middle">Neutropenia (24 hp1i)</td><td align="center" valign="middle">YES</td><td align="center" valign="middle">NO</td><td align="center" valign="middle">YES</td></tr><tr><td align="left" valign="middle">Emergency granulopoiesis (48 hp1i)</td><td align="center" valign="middle">YES</td><td align="center" valign="middle">NO</td><td align="center" valign="middle">NO</td></tr><tr><td align="left" valign="middle">Changes in macrophage population</td><td align="center" valign="middle">YES</td><td align="center" valign="middle">NO</td><td align="center" valign="middle">YES</td></tr><tr><td align="left" valign="middle">Induction pro-inflammatory responses</td><td align="center" valign="middle">YES</td><td align="center" valign="middle">NO</td><td align="center" valign="middle">YES</td></tr><tr><td align="center" valign="middle" rowspan="3"><bold>Infection challenge</bold></td><td align="left" valign="middle">Survival protection</td><td align="center" valign="middle">YES</td><td align="center" valign="middle">YES</td><td align="center" valign="middle">YES</td></tr><tr><td align="left" valign="middle">Infection control</td><td align="center" valign="middle">YES</td><td align="center" valign="middle">NO</td><td align="center" valign="middle">YES</td></tr><tr><td align="left" valign="middle">Non-specific</td><td align="center" valign="middle">YES</td><td align="center" valign="middle">YES</td><td align="center" valign="middle">YES</td></tr></tbody></table></table-wrap></floats-group></article>